Search Within

DOPAMINE
Results 1 - 631 of 631
Dopamine Receptor and Hypertension

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 3,Issue: 1
Page: 69-77
Authors: Chunyu Zeng, Gilbert M. Eisner, Robin A. Felder and Pedro A. Jose

Partial Dopamine Agonists and the Treatment of Psychosis

Journal: Current Neuropharmacology
Volume: 3,Issue: 1
Page: 3-8
Authors: Carol A. Tamminga

Dopamine and the Diseased Brain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 109-131
Authors: T. Kienast and A. Heinz

Dopamine: Agonists and Neurodegenerative Disorders

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-13
Authors: Saba Khanam and Yasir Hasan Siddique*

Schizophrenia: From Dopamine to Glutamate and Back

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 3
Page: 267-277
Authors: M. L. Carlsson, A. Carlsson and M. Nilsson

Phasic Dopamine Release in Appetitive Behaviors and Drug Addiction

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 2
Page: 195-213
Authors: Matthew J. Wanat, Ingo Willuhn, Jeremy J. Clark and Paul E.M. Phillips

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 141-147
Authors: C. A. Tamminga and A. Carlsson

Evidence that Cortical Dopamine is a Co-Transmitter in Noradrenergic Neurons

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 1
Page: 103-109
Authors: Paola Devoto and Giovanna Flore

Antidepressants Alter Mesostriatal Dopamine Interactions with Serotonin Signaling

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 4
Page: 453-461
Authors: Fu-Ming Zhou and John A. Dani

Excitability of Dopamine Neurons: Modulation and Physiological Consequences

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 79-97
Authors: F. J. White, X- T. Hu, M. Marinelli and C. N. Rudick

Advances in the Electrochemical Analysis of Dopamine

Journal: Current Analytical Chemistry
Volume: 13,Issue: 2
Page: 89-103
Authors: Margarita Stoytcheva*, Roumen Zlatev, Zdravka Velkova, Velizar Gochev, Gisela Montero, Lydia Toscano and Amelia Olivas

Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 1089-1099
Authors: Giulia Ferrari-Toninelli, Sara A. Bonini, Giovanna Cenini, Giuseppina Maccarinelli, Mariagrazia Grilli, Daniela Uberti and Maurizio Memo

D3 Dopamine Receptor and Essential Hypertension

Journal: Current Hypertension Reviews
Volume: 2,Issue: 3
Page: 247-253
Authors: Chunyu Zeng, Gilbert M. Eisner, Robin A. Felder and Pedro A. Jose

Allosteric Modulation of Dopamine Receptors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 6
Page: 555-561
Authors: John A. Schetz

Regulation of Blood Pressure by D5 Dopamine Receptors

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 241-248
Authors: Chunyu Zeng, Zhiwei Yang, Laureano D. Asico and Pedro A. Jose

Dopamine and Vascular Dynamics Control: Present Status and Future Perspectives

Journal: Current Neurovascular Research
Volume: 8,Issue: 3
Page: 246-257
Authors: Seyed Khosrow Tayebati, Mustafa F. Lokhandwala and Francesco Amenta

Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 104-106
Authors: Xingdang Liu, James Robert Brasic and Yun Zhou

Comparison of Cytocidal Activities of L-DOPA and Dopamine in S. cerevisiae and C. glabrata

Journal: Current Bioactive Compounds
Volume: 14,Issue: 0
Page: 1-3
Authors: Carmen Escorial and Ian Macreadie*

Buprenorphine and Naloxone Combinations and Dopamine

Journal: Current Psychopharmacology
Volume: 6,Issue: 2
Page: 111-121
Authors: Kenneth Blum*, Mark S. Gold, Edward J. Modestino, Marcel Febo, Panayotis K. Thanos, David Baron, Bruce Steinberg, Lyle Fried and Rajendra D. Badgaiyan

Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 245-252
Authors: Y. Takamatsu, Y. Hagino, A. Sato, T. Takahashi, S.Y. Nagasawa, Y. Kubo, M. Mizuguchi, G.R. Uhl, I. Sora and K. Ikeda

Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7,Issue: 3
Page: 236-242
Authors: Dragos Inta, Juan M. Lima-Ojeda, Peter Gass and Paolo Fusar-Poli

Dopamine Receptors are Involved in the Control of Opioid Antinociception in Mice

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 2
Page: 145-147
Authors: Anna Capasso

Structure-Based Drug Design for Dopamine D3 Receptor

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15,Issue: 1
Page: 775-791
Authors: Zhiwei Feng, Tingjun Hou and Youyong Li

Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 3-23
Authors: J. C. Glennon, W. J. Wadman, A. C. McCreary and T. R. Werkman

Phasic Dopamine Signaling During Behavior, Reward, and Disease States

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 99-108
Authors: R. M. Wightman and M. L.A.V. Heien

Dopamine Agonists in the Treatment of Parkinsons Disease-Past, Present and Future

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 1
Page: 1211-1248
Authors: S. Y. Sit

Neuroplasticity within the Mesoaccumbens Dopamine System and its Role in Tobacco Dependence

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 4
Page: 413-421
Authors: David J.K. Balfour

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 3
Page: 345-353
Authors: M. M. Lewis, X. Huang, D. E. Nichols and R. B. Mailman

Markers Associated with Sex Differences in Methamphetamine-Induced Striatal Dopamine Neurotoxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 40-44
Authors: D. E. Dluzen, J. L. McDermott, M. Bourque, T. Di Paolo, A. S. Darvesh, A. B. Buletko and N. J. Laping

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 1568-1579
Authors: Martin Bauer, Nicole Praschak-Rieder, Siegfried Kasper and Matthaus Willeit

Dopamine β-Monooxygenase: Mechanism, Substrates and Inhibitors

Journal: Current Enzyme Inhibition
Volume: 5,Issue: 1
Page: 27-43
Authors: Alexandre Beliaev, Humberto Ferreira, David A. Learmonth and Patricio Soares-da-Silva

Frontal Lobe Synaptic Plasticity in Development and Disease: Modulation by the Dopamine D1 Receptor

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 3
Page: 5194-5201
Authors: Lynn D. Selemon

A New Approach for Treatment of Hypertension: Modifying D1 Dopamine Receptor Function

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 4
Page: 369-377
Authors: Chunyu Zeng, Robin A. Felder and Pedro A. Jose

Dopamine Thioethers in Neurodegeneration

Journal: Current Topics in Medicinal Chemistry
Volume: 1,Issue: 6
Page: 519-527
Authors: Kathrin R. Sidell, Ventkataraman Amarnath and Thomas J. Montine

Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review

Journal: Current Neuropharmacology
Volume: 15,Issue: 1
Page: 174-183
Authors: John Yin, Alasdair M. Barr, Alfredo Ramos-Miguel and Ric M. Procyshyn

Unraveling the Dopamine Receptor Signalplex by DRIPs and DRAPs

Journal: Current Proteomics
Volume: 2,Issue: 3
Page: 209-223
Authors: N. Kabbani, M. A. Hannan and R. Levenson

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 3700-3724
Authors: Robert R. Luedtke, Claudia Rangel-Barajas, Mahinder Malik, David E. Reichert and R. H. Mach

Role of Dimerization in Dopamine D4 Receptor Biogenesis

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 659-665
Authors: Kathleen Van Craenenbroeck, Dasiel O. Borroto-Escuela, Kamila Skieterska, Jolien Duchou, Wilber Romero-Fernandez and Kjell Fuxe

Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 32-40
Authors: Donatella Marazziti, Giorgio Consoli, Irene Masala, Mario Catena Dell'Osso and Stefano Baroni

Dopamine Administration in Very Low Birth Weight Preterm Infants:Emerging Issues on Endocrine Effects

Journal: Current Pediatric Reviews
Volume: 3,Issue: 2
Page: 141-166
Authors: Luca Filippi, Chiara Poggi and Marco Pezzati

Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4,Issue: 1
Page: 47-59
Authors: Thomas Prisinzano, Kenner C. Rice, Michael H. Baumann and Richard B. Rothman

Agonistic and Antagonistic Bivalent Ligands for Serotonin and Dopamine Receptors Including their Transporters

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 4
Page: 347-353
Authors: Michael Decker and Jochen Lehmann

Role of Dopamine Signaling in Drug Addiction

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2440-2455
Authors: Wan Chen, Zhihuan Nong, Yaoxuan Li, Jianping Huang , Chunxia Chen* and Luying Huang*

Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development

Journal: Current Drug Targets
Volume: 13,Issue: 1
Page: 72-79
Authors: Nadine Kabbani, Mathew P. Woll, Jacob C. Nordman and Robert Levenson

Three-Dimensional Pharmacophore Mapping of a Series of Isoxazolylpiperazine Inhibitors Selectively Acting on the Dopamine D4 Receptor

Journal: Letters in Drug Design & Discovery
Volume: 1,Issue: 4
Page: 372-379
Authors: In Young Lee, Yeon Joo Lee, Yong Seo Cho, Ae Nim Pae and Hun Yeong Koh

4D-QSAR Model for Compounds with Binding Affinity Towards Dopamine D2 Receptors

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 5
Page: 649-664
Authors: Daniela Rodrigues Silva, Teodorico C. Ramalho and Elaine F. F. da Cunha

Nitric Oxide and Dopamine Neurons. Implications for Parkinsons Disease

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5,Issue: 3
Page: 193-205
Authors: Maria A. Mena, Maria J. Casarejos and Santiago Canals

Dopamine: The Forgotten Felon in Type 2 Diabetes

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 1
Page: 61-65
Authors: Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Satish Kumar

Dopamine D5 Receptors: A Challenge to Medicinal Chemists

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 976-995
Authors: G. Giorgioni, A. Piergentili, S. Ruggieri and W. Quaglia

The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-12
Authors: Kenneth Blum, Panayotis K Thanos, Gene-Jack Wang, Marcelo Febo, Zsolt Demetrovics, Edward Justin Modestino*, Eric R. Braverman, David Baron, Rajendra D. Badgaiyan and Mark S. Gold

Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?

Journal: Current Neuropharmacology
Volume: 16,Issue: 2
Page: 222-230
Authors: Marco Carli, Shivakumar Kolachalam, Stefano Aringhieri, Mario Rossi, Luca Giovannini, Roberto Maggio * and Marco Scarselli*

Modulation of Dopamine Transmission by 5HT2C and 5HT3 Receptors: A Role in the Antidepressant Response

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 165-175
Authors: Eliyahu Dremencov, Yifat Weizmann, Noa Kinor, Iris Gispan-Herman and Gal Yadid

Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 45-56
Authors: Raul R. Gainetdinov, Marc G. Caron, Jean-Martin Beaulieu and Tatyana D. Sotnikova

Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 304-316
Authors: S. Tanganelli, T. Antonelli, M. C. Tomasini, S. Beggiato, K. Fuxe and L. Ferraro

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 156-165
Authors: Yuji Odagaki

6-hydroxydopamine Lesion of the Mesolimbic Dopamine System Alters Morphine-Induced Conditioned Reinforcement

Journal: Current Psychopharmacology
Volume: 7,Issue: 0
Page: 1-8
Authors: S Tiffany Donaldson* and Brooke Plotkin

Progress in the Search for New Dopamine Transporter Inhibitors

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 2
Page: 3255-3277
Authors: Beata Gryzlo, Paula Zareba, Katarzyna Malawska, Anna Jakubowska and Katarzyna Kulig

Optimizing Contrast Effect in T1-Weighted Magnetic Resonance Imaging of Gd2O3-Based Nano-Agent via Dopamine Chelation

Journal: Neuroscience and Biomedical Engineering
Volume: 4,Issue: 4
Page: 249-254
Authors: Haitao Huang, Lihui Weng and Jafar Golzarian*

Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?

Journal: Current Neuropharmacology
Volume: 5,Issue: 4
Page: 268-277
Authors: M. Melis and M. Pistis

Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 1
Page: 70-77
Authors: Miriam Melis, Gianfranca Carta, Marco Pistis and Sebastiano Banni

Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands

Journal: Medicinal Chemistry
Volume: 8,Issue: 4
Page: 699-704
Authors: Gianfabio Giorgioni, Dario Ambrosini, Giovanni Filippo Palmieri, Barbara Costa, Antonio Di Stefano and Claudia Martini

A Solution-Phase Combinatorial Synthesis of Selective Dopamine D4 Ligands

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 3,Issue: 1
Page: 43-50
Authors: John P. Williams and Karine Lavrador

Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors

Journal: Current Drug Therapy
Volume: 2,Issue: 1
Page: 17-20
Authors: Samay Jain and Cheryl H. Waters

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 25-43
Authors: L. Leriche, E. Bezard, C. Gross, O. Guillin, B. L. Foll, J. Diaz and P. Sokoloff

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 2
Page: 214-223
Authors: Majid Pornour, Ghasem Ahangari, Seyed H. Hejazi and Abdolkhalegh Deezagi

Artificial Neural Network (ANN) Based Modelling for D1 Like and D2 Like Dopamine Receptor Affinity and Selectivity

Journal: Medicinal Chemistry
Volume: 6,Issue: 5
Page: 259-270
Authors: Dana A. Karolidis, Snezana Agatonovic-Kustrin and David W. Morton

Altered Mesolimbic Dopamine System in THC Dependence

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 200-204
Authors: S. Spiga, A. Lintas and M. Diana

Development of Polyfluorophenyltropanes: Potential Probes for 19F Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Assessments of the Dopamine Transporter

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 302-306
Authors: Ao Zhang, Nora S. Kula, Kehong Zhang, Ross J. Baldessarini, Marc J. Kaufman, Perry F. Renshaw and John L. Neumeyer

The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 855-859
Authors: Jia Li, John A. Dani and Weidong Le

Evaluation of 2,3,4,8,13a Hexahydro-1H-Benzo[5,6]Cyclohepta-6,7- Dihydroxy[1,2,3-ef][3]Benzazepine Derivatives as Dopamine Receptor Ligands

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 1
Page: 55-60
Authors: P. Sozio, F. Pinnen, A. Cocco, I. Cacciatore, G. Giorgioni, B. Costa, M. Montali, G. Spoto, F. Santoleri and Antonio Di Stefano

The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?

Journal: Current Drug Discovery Technologies
Volume: 15,Issue: 0
Page: 1-16
Authors: Hossein Bakhtou, Asiie Olfatbakhsh, Abdolkhaegh Deezagi and Ghasem Ahangari*

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 91-95
Authors: Y. Hagino, Y. Takamatsu, H. Yamamoto, T. Iwamura, D. L. Murphy, G. R. Uhl, I. Sora and K. Ikeda

On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?

Journal: Current Neuropharmacology
Volume: 4,Issue: 2
Page: 115-125
Authors: Paola Devoto and Giovanna Flore

Dopamine Transporter Ligands: Recent Developments and Therapeutic Potential

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 1825-1843
Authors: Scott P. Runyon and F. Ivy Carroll

Parallel Roles for Dopamine in Pathological Gambling and Psychostimulant Addiction

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 1
Page: 11-25
Authors: Martin Zack and Constantine X. Poulos

Brexpiprazole: A Partial Dopamine Agonist for the Treatment of Schizophrenia

Journal: Reviews on Recent Clinical Trials
Volume: 12,Issue: 0
Page: 1-8
Authors: Asli Ekinci and Okan Ekinci*

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 177-185
Authors: Ennio Esposito

The Discovery of Epidepride and Its Analogs as High-Affinity Radioligands for Imaging Extrastriatal Dopamine D2 Receptors in Human Brain

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 8
Page: 673-696
Authors: Tomas de Paulis

Assessment of a Synthetic Steroid and Flutamide on Dopamine, GSH and H2O2 Levels in Rat Brain in Presence of Fructose

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 14,Issue: 2
Page: 126-133
Authors: David C. Guzman, Eugene Bratoeff, Aylin S. Ortiz, Ernestina H. Garcia, Norma O. Brizuela, Gerardo B. Mejia, Hugo J. Olguin, Daniel S. del Angel and Israel M. Cruz

The Role of Autophagy on the Survival of Dopamine Neurons

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 869-879
Authors: Ciro Isidoro, Francesca Biagioni, Filippo Sean Giorgi, Federica Fulceri, Antonio Paparelli and Francesco Fornai

Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 2357-2374
Authors: Mercè Masana, Noemí Santana, Francesc Artigas and Analía Bortolozzi

Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 2
Page: 2972-2990
Authors: Vladimir Sukalovic, Vukic Soskic and Sladjana Kostic-Rajacic

Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 3957-3966
Authors: A. Banerjee and O. Prante

Significant Changes in D2-like Dopamine Gene Receptors Expression Associated with Non- Small -Cell Lung Cancer: Could it be of Potential Use in the Design of Future Therapeutic Strategies?

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 304-310
Authors: Mojhgan Shaikhpoor, Ghasem Ahangari, Majid Sadeghizadeh, Adnan Khosravi and Gholamreza Derakhshani Deilami

Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 526-538
Authors: Jean Lud Cadet, Subramaniam Jayanthi, Michael T. McCoy, Genevieve Beauvais and Ning Sheng Cai

Structure-Activity Relationships for Serotonin Transporter and Dopamine Receptor Selectivity

Journal: Medicinal Chemistry
Volume: 5,Issue: 3
Page: 271-278
Authors: Snezana Agatonovic-Kustrin, Paul Davies and Joseph V. Turner

Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 4
Page: 6392-6396
Authors: Amine Benyamina, Laurent Karila, Geneviève Lafaye and Lisa Blecha

Selective Dopamine D4 Receptor Antagonists: Review ofStructure-Activity Relationships

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2,Issue: 4
Page: 259-274
Authors: Kehong Zhang, Ross J. Baldessarini, Frank I. Tarazi and John L. Neumeyer

Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 393-409
Authors: J. Zhu and M. E.A. Reith

Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 57-77
Authors: Remco H.S. Westerink

Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1,Issue: 3
Page: 271-288
Authors: Fabrizio Micheli and Christian Heidbreder

HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System

Journal: Current HIV Research
Volume: 13,Issue: 1
Page: 21-42
Authors: Sylvia Fitting, Rosemarie M. Booze and Charles F. Mactutus

Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 507-512
Authors: Radek Ptacek, Hana Kuzelova, George B. Stefano, Jiri Raboch and Richard M. Kream

Combining Stress and Dopamine Based Models of Addiction: Towards a Psycho-Neuro-Endocrinological Theory of Addiction

Journal: Current Drug Abuse Reviews
Volume: 9,Issue: 1
Page: 61-74
Authors: James H. Johnston, David E.J. Linden and Marianne B.M. van den Bree

Dopamine-Glutamate Interaction and Antipsychotics Mechanism of Action: Implication for New Pharmacological Strategies in Psychosis

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 2
Page: 3561-3594
Authors: A. de Bartolomeis, G. Fiore and F. Iasevoli

Dopamine Neurons in the Ventral Tegmental Area: Drug-induced Synaptic Plasticity and Its Role in Relapse to Drug-seeking Behavior

Journal: Current Drug Abuse Reviews
Volume: 4,Issue: 4
Page: 270-285
Authors: WenLin Sun

Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 8
Page: 643-671
Authors: Robert R. Luedtke and Robert H. Mach

Changes in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to Neurodegeneration

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 211-219
Authors: Aaron M. Johnson, Laura M. Grant, Timothy Schallert and Michelle R. Ciucci

A Computational Perspective on Drug Discovery and Signal Transduction Mechanism of Dopamine and Serotonin Receptors in the Treatment of Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 1
Page: 916-926
Authors: Peng Lian, Lili Xu, Chuanrong Geng, Yuanyuan Qian, Wei Li, Xuechu Zhen and Wei Fu

The Control of Dopamine Neuron Development, Function and Survival: Insights From Transgenic Mice and The Relevance to Human Disease

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 1
Page: 857-870
Authors: J. B. Eells

Medications Acting on the Dopaminergic System in the Treatment of Alcoholic Patients

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 1
Page: 2136-2140
Authors: Robert Swift

Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate

Journal: Current Neuropharmacology
Volume: 6,Issue: 4
Page: 379-385
Authors: T. J. Volz

Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

Journal: Current Drug Targets
Volume: 10,Issue: 1
Page: 1069-1084
Authors: Bruno P. Guiard, Mostafa El Mansari and Pierre Blier

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 1068-1088
Authors: John H. Kehne, Terrance H. Andree and Julia N. Heinrich

The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 317-355
Authors: M. Filip, M. Zaniewska, M. Frankowska, K. Wydra and K. Fuxe

PET Tracers for Imaging of the Dopaminergic System

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 1
Page: 2139-2153
Authors: Kentaro Hatano, Kiichi Ishiwata and Philip H. Elsinga

Roles of a Novel Molecule ‘Shati’ in the Development of Methamphetamine-Induced Dependence

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 104-108
Authors: Minae Niwa and Toshitaka Nabeshima

Assessing Dopaminergic Neurotransmission with PET: Basic Theory and Applications in Alcohol Research

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 118-124
Authors: Karmen K. Yoder, David A. Kareken and Evan D. Morris

Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 410-421
Authors: Christian Heidbreder

Current State of Agonist Radioligands for Imaging of Brain Dopamine D2/D3 Receptors In Vivo with Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 1477-1498
Authors: Sjoerd J. Finnema, Benny Bang-Andersen, Hakan V. Wikstrom and Christer Halldin

Capillary Electrophoresis Study on DNA-Protein Complex Formation in the Polymorphic 5 Upstream Region of the Dopamine D4 Receptor (DRD4) Gene

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1023-1029
Authors: Z. Ronai, A. Guttman, G. Keszler and M. Sasvari-Szekely

Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 596-600
Authors: Sergi Ferre, Carmen Lluis, Jose Luis Lanciego and Rafael Franco

Region-Specific Dendritic Spine Loss of Pyramidal Neurons in Dopamine Transporter Knockout Mice

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 237-244
Authors: Y. Kasahara, Y. Arime, F.S. Hall, G.R. Uhl and I. Sora

Simultaneous Determination of Dopamine and Uric Acid in the Presence of Ascorbic Acid at the Indole-3-Carboxaldehyde Modified Glassy Carbon Electrode

Journal: Current Analytical Chemistry
Volume: 6,Issue: 3
Page: 203-208
Authors: Didem Deletioglu, Erdogan Hasdemir and Ali O. Solak

The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico- Subcortical Regions

Journal: Current Molecular Pharmacology
Volume: 6,Issue: 3
Page: 149-155
Authors: Felice Iasevoli, Luigi Aloj, Gianmarco Latte, Livia Avvisati, Federica Marmo, Carmine Tomasetti, Elisabetta F. Buonaguro, Chiara Simeoli, Rosario Pivonello, Annamaria Colao and Andrea de Bartolomeis

An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1468-1474
Authors: S. Ferre, C. Quiroz, A. S. Woods, R. Cunha, P. Popoli, F. Ciruela, C. Lluis, R. Franco, K. Azdad and S. N. Schiffmann

A Colorimetric Sensor for Dopamine Detection Based on Peroxidase-like Activity of Ce2(MoO4)3 Nanoplates

Journal: Current Pharmaceutical Analysis
Volume: 14,Issue: 0
Page: 1-7
Authors: Mehdi Rahimi-Nasrabadi*, Morteza Hosseini, Amir Homayoun Keihan and Mohammad Reza Ganjali

Regulation of Corticostriatal Synaptic Plasticity by G Protein-Coupled Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 601-615
Authors: Rakel Lopez de Maturana and Rosario Sanchez-Pernaute

Reactive Astrocytes as Potential Manipulation Targets in Novel Cell Replacement Therapy of Parkinsons Disease

Journal: Current Drug Targets
Volume: 6,Issue: 7
Page: 821-833
Authors: L- W. Chen, K- L. Yung and Y- S. Chan

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 163-181
Authors: Frank P. Bymaster, Christian Felder, Saeed Ahmed and David McKinzie

Neuroleptics and Migraine

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 63-70
Authors: Petcharat Dusitanond and William B. Young

Estradiol, Dopamine and Motivation

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 83-89
Authors: Katie E. Yoest, Jennifer A. Cummings and Jill B. Becker

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 1580-1592
Authors: Thomas L. Schwartz, Shilpa Sachdeva and Stephen M. Stahl

Synthesis and Pharmacological Evaluation of 4-Phenoxy-1,2,3,4- Tetrahydroisoquinolines and 4,5,6,6a-Tetrahydrochromeno [2,3,4-de]isoquinolines

Journal: Medicinal Chemistry
Volume: 4,Issue: 1
Page: 1-10
Authors: G. Giorgioni, S. Ruggieri, F. Claudi, A. Di Stefano, E. Ljung and T. Carlsson

Individual Differences and Vulnerability to Drug Addiction: A Focus on the Endocannabinoid System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 502-517
Authors: Claudia Sagheddu and Miriam Melis

The NMDA/D1 Receptor Complex as a New Target in Drug Development

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 8
Page: 801-808
Authors: Cristina Missale, Chiara Fiorentini, Chiara Busi, Ginetta Collo and P. F. Spano

Anti-Inflammatory Agents in Parkinsons Disease

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 72-84
Authors: Carla Iarlori

Dopaminergic Modulation of Cognitive Control: Distinct Roles for the Prefrontal Cortex and the Basal Ganglia

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 1
Page: 2026-2032
Authors: Martine van Schouwenburg, Esther Aarts and Roshan Cools

From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 4
Page: 459-465
Authors: O. D. Howes, P. Fusar-Poli, M. Bloomfield, S. Selvaraj and P. McGuire

Noradrenaline in Parkinsons Disease: From Disease Progression to Current Therapeutics

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2330-2334
Authors: Francesco Fornai, Adolfo Bandettini di Poggio, Antonio Pellegrini, Stefano Ruggieri and Antonio Paparelli

Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 6
Page: 687-693
Authors: M. Murata

Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 1
Page: 1-26
Authors: Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco and Luigi Agnati

Predicting Dopamine Receptors Binding Affinity of N-[4-(4-Arylpiperazin- 1-yl) butyl]Aryl Carboxamides: Computational Approach Using Topological Descriptors

Journal: Current Drug Discovery Technologies
Volume: 2,Issue: 2
Page: 115-121
Authors: Viney Lather and A. K. Madan

Filtering Disturbances in Schizophrenic Patients. Gating of Auditory Evoked Potentials and Prepulse Inhibition of the Acoustic Startle Response Compared. Emphasis on the Role of Dopamine

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 47-87
Authors: N. M.W.J. de Bruin, E. L.J.M. van Luijtelaar, A. R. Cools and B. A. Ellenbroek

Modulation of Midbrain Dopamine Neurotransmission by Serotonin, a Versatile Interaction Between Neurotransmitters and Significance for Antipsychotic Drug Action

Journal: Current Neuropharmacology
Volume: 4,Issue: 1
Page: 59-68
Authors: J. E. Olijslagers, T. R. Werkman, A. C. McCreary, C. G. Kruse and W. J. Wadman

Frequency of Pituitary Tumor Apoplexy During Treatment of Prolactinomas with Dopamine Agonists: A Systematic Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 1012-1014
Authors: Robert Carija and Diana Vucina

Dopamine D3 Agonists in the Treatment of Parkinson's Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 908-926
Authors: Banibrata Das, Gyan Modi and Aloke Dutta

Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9,Issue: 2
Page: 94-101
Authors: Michel C.F. Shamy, Clement Zai, Vincenzo S. Basile, James L. Kennedy, Daniel J. Muller and Mario Masellis

Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy

Journal: Current Gene Therapy
Volume: 7,Issue: 2
Page: 109-120
Authors: Thomas Carlsson, Tomas Bjorklund and Deniz Kirik

α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 482-490
Authors: Gianfranco Bazzu, Giammario Calia, Giulia Puggioni, Ylenia Spissu, Gaia Rocchitta, Patrizia Debetto, Jessica Grigoletto, Morena Zusso, Rossana Migheli, Pier Andrea Serra, Maria Speranza Desole and Egidio Miele

Behavioural Sensitisation During Dopamine Replacement Therapy in Parkinsons Disease is Reminiscent of the Addicted Brain

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 894-902
Authors: F. Biagioni, A. Pellegrini, S. Ruggieri, L. Murri, A. Paparelli and F. Fornai1

Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 449-458
Authors: L. W. Chen, F. Kuang, L. C. Wei, Y. X. Ding, K. K.L. Yung and Y. S. Chan

Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders

Journal: Current Drug Therapy
Volume: 6,Issue: 1
Page: 17-34
Authors: Aravind Mittur

Functional Neurochemistry of Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 3
Page: 265-293
Authors: Wieland Gsell, Gerd Jungkunz and Peter Riederer

Current Strategies for the Development of Novel Antipsychotic Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3,Issue: 3
Page: 239-251
Authors: Jordi Bolos

Working Memory in ADHD: Prefrontal/Parietal Connections

Journal: Current Drug Targets
Volume: 2,Issue: 4
Page: 347-352
Authors: F Levy and M Farrow

Personality and Genetics

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 2
Page: 147-159
Authors: Alessandro Serretti, Raffaella Calati, Barbara Ferrari and Diana De Ronchi

Endocannabinoids and Drug Dependence

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 6
Page: 643-655
Authors: Daniela Parolaro, Daniela Vigano and Tiziana Rubino

Catecholaminergic Strategies for the Treatment of Major Depression

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 149-158
Authors: Philippe Tremblay and Pierre Blier

Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4,Issue: 3
Page: 230-240
Authors: Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta and Massimo Di Giannantonio

Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 30-34
Authors: E. Y. Jang, M. Hwang, S. S. Yoon, J. R. Lee, K. J. Kim, H.-C. Kim and C. H. Yang

Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease

Journal: Current Neuropharmacology
Volume: 5,Issue: 1
Page: 35-46
Authors: Randy L. Hunter and Guoying Bing

GDNF Family Ligands: A Potential Future for Parkinsons Disease Therapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 703-711
Authors: Amanda L. Mickiewicz and Jeffrey H. Kordower

Functional Imaging of Neurotransmission

Journal: Current Medical Imaging Reviews
Volume: 3,Issue: 4
Page: 220-224
Authors: Alan J. Fischman and Rajendra D. Badgaiyan

Effects of Behavioral and Neurochemical Changes on Adult Excitotoxic Lesion of the Ventral Hippocampus

Journal: Medicinal Chemistry
Volume: 3,Issue: 3
Page: 255-260
Authors: Yi Ru Fang, Tomohiro Abekawa, Koki Ito, Xiao Bai Li and Tsukasa Koyama

The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 306-323
Authors: E. M. Tunbridge, A. Huber, S. M. Farrell, K. Stumpenhorst, P. J. Harrison and M. E. Walton

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate

Journal: Current Neuropharmacology
Volume: 6,Issue: 4
Page: 322-328
Authors: Veronika Engert and Jens C. Pruessner

An Update on Adenosine A2A Receptors as Drug Target in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 659-669
Authors: Antoni Vallano, Víctor Fernandez-Duenas, Consuelo Pedros, Josep Maria Arnau and Francisco Ciruela

Sex Hormones and Brain Dopamine Functions

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 62-71
Authors: Ramon Sotomayor-Zarate, Gonzalo Cruz, Georgina M. Renard, Pedro Espinosa and Victor D. Ramirez

Abnormal Striatal Dopamine Transmission in Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 397-404
Authors: Jerome Brunelin, Shirley Fecteau and Marie-Francoise Suaud-Chagny

Dopamine Pharmacological Agents in Resistant-OCD

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 44-46
Authors: Stefano Pallanti, Giacomo Grassi and Iuliia Burian

Editorial (Thematic Issue: Dopamine in the Brain)

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 61-61
Authors: Victor D. Ramirez

A Candidate Pathway Strategy for Integration of Pharmacogenomic Components of Variability in Antipsychotic Treatment Outcomes: A Focus on Aripiprazole

Journal: Current Pharmacogenomics
Volume: 3,Issue: 4
Page: 305-317
Authors: Christopher Reist, Lawrence J. Albers, Stephen R. Marder, Bryn Williams-Jones, Joseph C. Wu, Steven Mee, Kazutaka Shimoda, Toshiyuki Someya and Vural Ozdemir

Current Status of Antipsychotic Treatment

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 123-128
Authors: Robert R. Conley and Deanna L. Kelly

A Review of Current Drug Targets and Pharmacology of Antipsychotic Treatment

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 3
Page: 177-182
Authors: Robert R. Conley and Deanna L. Kelly

The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2421-2428
Authors: Francesco Fornai, Riccardo Ruffoli, Paola Soldani, Stefano Ruggieri and Antonio Paparelli

Approaches to Enantiomerically Pure 3,4-Dihydro-2H-1-Benzopyran-3-Amines

Journal: Current Organic Chemistry
Volume: 14,Issue: 6
Page: 581-600
Authors: A. Beliaev, B. Broadbelt and D. A. Learmonth

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 137-150
Authors: Jan Kehler and Jacob Nielsen

Carbohydrate Reward and Psychosis: An Explanation For Neuroleptic Induced Weight Gain and Path to Improved Mental Health?

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 370-375
Authors: Simon Thornley, Bruce Russell and Rob Kydd

Pharmacological Therapy of Parkinsons Disease: Current Options and New Avenues

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 5,Issue: 3
Page: 221-238
Authors: Nicola Simola, Annalisa Pinna and Sandro Fenu

Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis

Journal: Current Drug Targets
Volume: 7,Issue: 9
Page: 1205-1215
Authors: David L. Garver

Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 2
Page: 129-139
Authors: Reiner Oberbeck

Schizophrenia: Redox Regulation and Volume Neurotransmission

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 289-300
Authors: I. Bokkon and I. Antal

Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 7
Page: 565-574
Authors: T. A. Kato, A. Monji, Y. Mizoguchi, S. Hashioka, H. Horikawa, Y. Seki, M. Kasai, H. Utsumi and S. Kanba

Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 999-1015
Authors: Christina Gianoulakis

Schizophrenia and Bipolar Affective Disorder: Perspectives for the Development of Therapeutics

Journal: Current Molecular Medicine
Volume: 3,Issue: 5
Page: 393-407
Authors: S. Sundram, P. R. Joyce and M. A. Kennedy

Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 3
Page: 437-448
Authors: Aaron J. Kucinski, Michal K. Stachowiak, Scott R. Wersinger, Patrick M. Lippiello and Merouane Bencherif

PET Imaging in Parkinsons Disease

Journal: Current Medical Imaging Reviews
Volume: 3,Issue: 4
Page: 233-241
Authors: Vijay Dhawan and David Eidelberg

Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 988-1001
Authors: Vukic Soskic, Vladimir Sukalovic and Sladjana Kostic-Rajacic

Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 1
Page: 39-50
Authors: Christina Gianoulakis

The Sensation Seeking Trait and Substance Use: Research Findings and Clinical Implications

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 1
Page: 3-13
Authors: Michael T. Bardo, Yolanda Williams, Linda P. Dwoskin, S. E. Moynahan, I. B. Perry and Catherine A. Martin

Neurotransmitter Imaging: Basic Concepts and Future Perspectives

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 98-103
Authors: Rajendra D. Badgaiyan

The Neuropharmacology of Implicit Learning

Journal: Current Neuropharmacology
Volume: 8,Issue: 4
Page: 367-381
Authors: Julia Udden, Vasiliki Folia and Karl Magnus Petersson

Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 1883-1896
Authors: Craig W. Lindsley, Scott E. Wolkenberg and Gene G. Kinney

Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 8
Page: 975-988
Authors: Jacobus P. Petzer and Anel Petzer

Dopaminergic Enhancement of Cognitive Function

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 2
Page: 2487-2500
Authors: Mitul A. Mehta and Wim J. Riedel

Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 4
Page: 273-281
Authors: Liang-Wei Chen, Yan-Qin Wang, Li-Chun Wei, Mei Shi and Ying-Shing Chan

Metamphetamine Psychosis: How is it Related to Schizophrenia? A Review of the Literature

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 115-122
Authors: Melinda Sweeting and Michael Farrell

Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 4
Page: 445-452
Authors: Martyn D. Wood, Claire Scott, Kirsten Clarke, Katherine J. Cato, Nisha Patel, Jennie Heath, Angela Worby, Laurie Gordon, Lorraine Campbell, Graham Riley, Ceri H. Davies, Andrew Gribble and Declan N.C. Jones

Dopaminergic Modulation of Sleep-Wake States

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 4
Page: 380-386
Authors: Andrea Herrera-Solis, Wendy Herrera-Morales, Luis Nunez-Jaramillo and Oscar Arias-Carrion*

Agonist Replacement for Stimulant Dependence: A Review of Clinical Research

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 4
Page: 7026-7035
Authors: William W. Stoops and Craig R. Rush

Commentary

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 192-192
Authors: Stephen D. Skaper


An Overview on Benzylisoquinoline Derivatives with Dopaminergic and Serotonergic Activities

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 1
Page: 2441-2467
Authors: N. Cabedo, I. Berenguer, B. Figadere and D. Cortes

Catechol-O-Methyl Transferase Modulates Cognition in Late Life: Evidence and Implications for Cognitive Enhancement

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 195-208
Authors: Fabio Sambataro, Maria Pennuto and Robert Christian Wolf

Would Polymorphic Variants of Dopamine-2 Receptor Gene (DRD2) and Serotonin Transporter Gene (SERT) be a Common Genetic Risk Factor for Comorbid Drug Abuse and Myocardial Ischemia? A Hypothesis- generating Study

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 15,Issue: 2
Page: 129-143
Authors: Yasmeen M. Taalab*, Doaa A. Elmorsi, Imke Puls, Andreas Heinz, Abdel-Aziz Ghanem, Seham Gad-ElHak and Mohammad Al-Haggar

Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 5
Page: 502-515
Authors: Xavier Lopez-Gil, Francesc Artigas and Albert Adell

Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 4
Page: 6366-6379
Authors: Aviv Weinstein, Abigail Livny and Abraham Weizman

Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder

Journal: Current Neuropharmacology
Volume: 15,Issue: 6
Page: 831-860
Authors: Janine Naß and Thomas Efferth*

Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1512-1524
Authors: Rodrigo A. Cunha, Sergi Ferre, Jean-Marie Vaugeois and Jiang-Fan Chen

Treatment of Schizophrenia and Comorbid Substance Use Disorder

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 129-139
Authors: Alan I. Green, Melinda S. Salomon, Mark J. Brenner and Kimberly Rawlins

Role of Ghrelin in Drug Abuse and Reward-Relevant Behaviors: A Burgeoning Field and Gaps in the Literature

Journal: Current Drug Abuse Reviews
Volume: 6,Issue: 3
Page: 231-244
Authors: A.R. Revitsky and L.C. Klein

Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 50-54
Authors: Derick E. Vergne and Raymond F. Anton

May Exercise Prevent Addiction?

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 45-48
Authors: C. A. Fontes-Ribeiro, E. Marques, F. C. Pereira, A. P. Silva and T. R. A. Macedo

Clinical Management of the Cardiovascular Failure in Sepsis

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 2
Page: 222-242
Authors: Daniel De Backer and Sabino Scolletta

High Throughput Screening and Molecular Docking of Calmodulin with Antagonists of Trifluoperazine and Phenothiazine Chemical Class

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 0
Page: 1-7
Authors: Abdelmonem Messaoudi*, Zarrin Basharat and Asif Naqvi

Central Oxytocinergic Neurotransmission: A Drug Target for the Therapy of Psychogenic Erectile Dysfunction

Journal: Current Drug Targets
Volume: 4,Issue: 1
Page: 55-66
Authors: M. R. Melis and A. Argiolas

Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 3
Page: 381-393
Authors: Kunio Yui, Yasushi Kajii and Toru Nishikawa

CART Peptides as Targets for CNS Drug Development

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 3
Page: 201-205
Authors: Richard G. Hunter and Michael J. Kuhar

Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 1491-1495
Authors: David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera, Hugo Juárez Olguín, Ernestina Hernández García, Armando Valenzuela Peraza and Gerardo Barragán Mejía

Aminergic Control and Modulation of Honeybee Behaviour

Journal: Current Neuropharmacology
Volume: 4,Issue: 4
Page: 259-276
Authors: R. Scheiner, A. Baumann and W. Blenau

Targeting the Progression of Parkinsons Disease

Journal: Current Neuropharmacology
Volume: 7,Issue: 1
Page: 9-36
Authors: J. L. George, S. Mok, D. Moses, S. Wilkins, A. I. Bush, R. A. Cherny and D. I. Finkelstein

Commentary-2: Repairing the Dopamine System in the Brain with Adult Neurogenesis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 1
Page: 1635-1636
Authors: Ti-Fei Yuan and Oscar Arias-Carrion

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 3385-3403
Authors: Peng Li, Gretchen L. Snyder and Kimberly E. Vanover

Increased Mitochondrial DNA Deletions in Substantia Nigra Dopamine Neurons of the Aged Rat

Journal: Current Aging Science
Volume: 7,Issue: 3
Page: 155-160
Authors: Gemma M. Parkinson, Christopher V. Dayas and Doug W. Smith

From Stem Cells to Dopamine Neurons: Developmental Biology Meets Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 7
Page: 893-896
Authors: Jignesh Tailor, Thomas Andreska and Raja Kittappa

Modulation of T-cell Mediated Immunity by Dopamine Receptor D5

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 13,Issue: 2
Page: 184-194
Authors: Carolina Prado, Sebastian Bernales and Rodrigo Pacheco

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 1,Issue: 1
Page: 89-99
Authors: A. Michael Crider and Mark A. Scheideler

Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 899-918
Authors: Xin Li and Shutao Ma

The Contribution of Dopamine to the Implementation of Reward Value During the Control of Action

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 72-84
Authors: Johan Lauwereyns

Recent Progress in Medicinal Chemistry of D4 Agonists

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 2
Page: 2981-2993
Authors:

The Role of Cytokine Network in the Pathophysiology of Schizophrenia

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 123-131
Authors: Yong-Ku Kim

Electrochemical Pretreatment of Carbon Fiber Microelectrodes Based on Sinusoidal-wave Potential Cycling and its Application to Amperometric Sensing of Bioactive Compounds

Journal: Current Analytical Chemistry
Volume: 9,Issue: 2
Page: 305-311
Authors: Vladimir Halouzka, Jan Hrbac, David Jirovsky, Daniel Riman, Petr Jakubec, Zdenka Bartosova, Vlastimil Masek, Peter Mojzes and Jan Vacek

Fluorinated Tropanes

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 920-935
Authors: Jeffrey S. Stehouwer

Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 2314-2323
Authors: E.L. Schaeffer, W.F. Gattaz and G.P. Eckert

Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 2
Page: 141-149
Authors: Phil Skolnick and Anthony S. Basile

Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 1
Page: 2-9
Authors: Elizabeth Gilday and Henry A. Nasrallah

Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 331-344
Authors: T. A. Kato, Y. Yamauchi, H. Horikawa, A. Monji, Y. Mizoguchi, Y. Seki, K. Hayakawa, H. Utsumi and S. Kanba

Pituitary Microadenoma Treated with Antipsychotic Drug Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 1
Page: 58-60
Authors: Richard J. Wix-Ramos, Reinalis Paez, Eduardo Capote and Uribe Ezequiel

Challenge and Therapeutic Studies Using Alpha-Methyl-para-Tyrosine (AMPT) in Neuropsychiatric Disorders: A Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 249-256
Authors: Oswald J.N. Bloemen, M. B. de Koning, E. Boot, J. Booij and T.A. M.J. van Amelsvoort

Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1475-1489
Authors: N. Simola, M. Morelli and A. Pinna

Recent Developments in Neurochemical Imaging in Schizophrenia: An Update

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 351-356
Authors: Nora S. Vyas, Neva H. Patel, Peter Herscovitch, Basant K. Puri and Rupert Lanzenberger

An Overview of Parkinsons Disease and the Cannabinoid System and Possible Benefits of Cannabinoid-Based Treatments

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 3
Page: 3705-3718
Authors: Isabel Lastres-Becker and Javier Fernandez-Ruiz

L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 3
Page: 3482-3493
Authors: Antonio Di Stefano, Piera Sozio, Laura Serafina Cerasa and Antonio Iannitelli

Folate Status and Depressive Symptoms in Reproductive-Age Women

Journal: Current Nutrition & Food Science
Volume: 7,Issue: 2
Page: 96-102
Authors: Hiroko Watanabe, Takashi Sugiyama, Hiromitsu Chihara and Hideoki Fukuoka

Pharmacogenetic Approach for a Better Drug Treatment in Children

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 2
Page: 2462-2473
Authors: Guilherme Polanczyk, Marcelo P. Bigarella, Mara H. Hutz and Luis Augusto Rohde

Disulfiram: An Old Therapeutic with New Applications

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 5-12
Authors: Kelly S. Barth and Robert J. Malcolm

Exploring Mechanisms Underlying Extinction of Cue-Elicited Cocaine Seeking

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 8-11
Authors: Han Kong and Ming Xu

Sulfation in Dog

Journal: Current Drug Metabolism
Volume: 6,Issue: 3
Page: 275-285
Authors: C. Tsoi and S. Swedmark

Parkinsons Disease - Redox Mechanisms

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 7
Page: 809-814
Authors: James David Adams Jr., Mei-Ling Chang and Lori Klaidman

Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 1
Page: 1832-1845
Authors: A. Napolitano, P. Manini and M. d'Ischia

Novel 11,12H-dihydronaphthalene[1,2-b]quinoline as Atypical Antipsychotic

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 0
Page: 1-10
Authors: Maria Matilde Ramirez Moran, Jorge Eduardo Angel Guio*, Natividad Herrera Cano, Biagina del Carmen Migliore, Rodolfo Izquierdo, Jaime Charris, Simon Lopez, Anita Israel, Ana Santiago, Roberto Rossi, Luis Perdomo, Akram Samear Dabian, Mariagracia Vera Sosa, Alejandra Villalba and Ligia Biagina Angel Migliore

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

Journal: Current Drug Targets
Volume: 7,Issue: 1
Page: 1513-1529
Authors: Manuchair Ebadi, Holly Brown-Borg, Jun Ren, Sushil Sharma, Shaik Shavali, Hesham El ReFaey and Edward C. Carlson

Positron Emission Tomography and Brain Monoamine Neurotransmission - Entries for Study of Drug Interactions

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 1
Page: 1417-1434
Authors: P. Hartvig, M. Bergstrom, G. Antoni and B. Langstrom

Curcumin: A Potential Neuroprotective Agent in Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 91-99
Authors: R. B. Mythri and M. M. Srinivas Bharath

Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 1
Page: 1-16
Authors: M. J. Marino and P. Jeffrey Conn

Recent Developments in Studies of l-Stepholidine and its Analogs: Chemistry, Pharmacology and Clinical Implications

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 2
Page: 2996-3002
Authors: Jiao Mo, Yang Guo, Yu-She Yang, Jing-Shan Shen, Guo-Zhang Jin and Xuechu Zhen

Serotonergic Drugs for Depression and Beyond

Journal: Current Drug Targets
Volume: 14,Issue: 5
Page: 578-585
Authors: Stephen M. Stahl, Clara Lee-Zimmerman, Sylvia Cartwright and Debbi Ann Morrissette

Diverse Facets of COMT: From a Plausible Predictive Marker to a Potential Drug Target for Schizophrenia

Journal: Current Molecular Medicine
Volume: 11,Issue: 9
Page: 732-743
Authors: M. Gupta, H. Kaur, A. Jajodia, S. Jain, K. Satyamoorthy, M. Mukerji, J. Thirthalli and R. Kukreti

Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity

Journal: Current Physical Chemistry
Volume: 6,Issue: 1
Page: 40-52
Authors: Lucilene R. de Souza, Rafael de Matos Picanço, Abraão A. Pinheiro, Karina R. da Silva, Carlton A. Taft, Carlos H. T. de Paula da Silva, Cleydson B. R. dos Santos and Lorane I. da Silva Hage-Melim

Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 264-272
Authors: Neslihan Aygun Kocabas

Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment

Journal: Current Signal Transduction Therapy
Volume: 8,Issue: 2
Page: 119-128
Authors: Felice Iasevoli, Livia Avvisati, Gianmarco Latte, Elisabetta F. Buonaguro, Carmine Tomasetti, Luigi Aloj and Andrea de Bartolomeis

The Role of α5 GABAAReceptor Agonists in the Treatment of Cognitive Deficits in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 3
Page: 5069-5076
Authors: Kathryn M. Gill and Anthony A. Grace

Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 3
Page: 246-252
Authors: Deepak Purushotham, Chaiti Ganguly and Chiranjib Chakraborty

From Ancient Chinese Medicine to a Novel Approach to Treat Cocaine Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 716-726
Authors: Ivan Diamond and Lina Yao



Journal: Current Drug Safety
Volume: 7,Issue: 1
Page: 63-75
Authors: Michele Raja and Anna Rita Bentivoglio

Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 5
Page: 471-488
Authors: Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari and Marcio Lazzarini

Glutamate and Schizophrenia

Journal: Current Neuropharmacology
Volume: 1,Issue: 4
Page: 351-370
Authors: B. N.M. van Berckel

Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson s Disease and Huntington s Disease: A Review

Journal: Current Neuropharmacology
Volume: 16,Issue: 0
Page: 1-10
Authors: Sumit Jamwal and Puneet Kumar *



Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 238-246
Authors: Amir Sarrafchi, Mahmoud Bahmani, Hedayatollah Shirzad and Mahmoud Rafieian-Kopaei

Ibopamine Stimulates α-Adrenergic Receptors and D1 Dopaminergic Receptors in the Eye

Journal: Current Drug Therapy
Volume: 2,Issue: 2
Page: 127-132
Authors: Italo Giuffre

Towards Next Generation Adenosine A2A Receptor Antagonists

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 3
Page: 3918-3935
Authors: G. Yuan and G.B. Jones


A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 0
Page: 1-8
Authors: Letitia Meiring, Jacobus P. Petzer and Anél Petzer*

Could Sigma Receptor Ligands be a Treatment for Methamphetamine Addiction?

Journal: Current Drug Abuse Reviews
Volume: 3,Issue: 3
Page: 156-162
Authors: Kelli R. Rodvelt and Dennis K. Miller

Recent Progress of Imaging Agents for Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 12,Issue: 6
Page: 551-563
Authors: Xiaoai Wu, Huawei Cai, Ran Ge, Lin Li and Zhiyun Jia

Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5,Issue: 1
Page: 66-68
Authors: Georgios I. Tagarakis, Georgios E. Stylianakis and Nikolaos B. Tsilimingas

Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Journal: Current Molecular Imaging (Discontinued)
Volume: 3,Issue: 1
Page: 15-26
Authors: Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang, Hong-Wen Chen and Jeng-Jong Hwang

The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies

Journal: Medicinal Chemistry
Volume: 12,Issue: 6
Page: 500-505
Authors: Burak Yulug, Lütfü Hanoglu, Ahmet M. Tavli, Nesrin H. Yılmaz and Ertugrul Kılıc

GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 843-849
Authors: Maria Cerrillo Martinez, Francisco J. Ruiz and Juan A. García-Velasco

The Role of the Catechol-o-Methyltransferase (COMT) GeneVal158Met in Aggressive Behavior, a Review of Genetic Studies

Journal: Current Neuropharmacology
Volume: 13,Issue: 6
Page: 802-814
Authors: Arqam Qayyum, Clement C. Zai, Yuko Hirata, Arun K. Tiwari, Sheraz Cheema, Behdin Nowrouzi, Joseph H. Beitchman and L. Kennedy

Role of Descending Aminergic Pathways in the Development of Locomotion

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 2
Page: 4332-4340
Authors: Edouard Pearlstein

Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 212-220
Authors: M. Beatriz Currier and Charles B. Nemeroff

Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts

Journal: Current Pediatric Reviews
Volume: 5,Issue: 2
Page: 71-78
Authors: Chloe Joynt and Po-Yin Cheung

Novel Targets for Drugs in Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 4
Page: 265-272
Authors: J.M. Stone and L.S. Pilowsky

The Neuroprotective Role of Vesicular Monoamine Transporter 2 in Neurodegenerative Diseases

Journal: Medicinal Chemistry
Volume: 11,Issue: 2
Page: 104-108
Authors: Burak Yulug, Lutfu Hanoglu and Ertugrul Kilic

Roles of Renal Proximal Tubule Transport in the Pathogenesis of Hypertension

Journal: Current Hypertension Reviews
Volume: 9,Issue: 2
Page: 148-155
Authors: Shoko Horita, George Seki, Hideomi Yamada, Masashi Suzuki, Kazuhiko Koike and Toshiro Fujita

Imaging Endogenous Neurotransmitters In Vivo with Positron Emission Tomography Displacement Studies

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 29-43
Authors: Giampaolo Tomasi

Restless Leg Syndrome Associated with Atypical Antipsychotics: Current Status, Pathophysiology, and Clinical Implications

Journal: Current Drug Safety
Volume: 10,Issue: 2
Page: 98-105
Authors: Shilpa Aggarwal, Seetal Dodd and Michael Berk

Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 9
Page: 1380-1404
Authors: J. K. Shin, D. T. Malone, I. T. Crosby and B. Capuano

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1330-1330
Authors: Micah L. Breininger and Craig W. Lindsley

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

Journal: Current Neuropharmacology
Volume: 12,Issue: 3
Page: 219-238
Authors: Felice Iasevoli, Carmine Tomasetti, Elisabetta F. Buonaguro and Andrea de Bartolomeis

Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 1
Page: 1313-1355
Authors: Lin-Lin Wang, An-Kui Yang, Shu-Ming He, Jun Liang, Zhi-Wei Zhou, Yong Li and Shu-Feng Zhou

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 4
Page: 425-439
Authors: Livia Dezsi and Laszlo Vecsei*

Neurotransmitter and Imaging Studies in Anorexia Nervosa: New Targets for Treatment

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 1
Page: 61-72
Authors: Nicole C. Barbarich, Walter H. Kaye and David Jimerson

Anti-Aggressive, Brain Neurotransmitters and Receptor Binding Study of Fumaria indica in Rodents

Journal: Current Psychopharmacology
Volume: 1,Issue: 3
Page: 195-202
Authors: Gireesh Kumar Singh, Geeta Rai, Shyam Sunder Chatterjee and Vikas Kumar

Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease

Journal: Current Drug Targets
Volume: 5,Issue: 2
Page: 197-206
Authors: L.- W. Chen, K. K.L. Yung and Y S Chan

Voltammetric Determination of Ophthalmic Drug Dexamethasone Using Poly-glycine Multi Walled Carbon Nanotubes Modified Paste Electrode

Journal: Current Analytical Chemistry
Volume: 13,Issue: 0
Page: 1-7
Authors: Ersin Demir, Onur Inam, Recai Inam and Hassan Y. Aboul-Enein*

Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity

Journal: Current Neuropharmacology
Volume: 15,Issue: 8
Page: 1192-1207
Authors: Erin W Tuplin * and Matthew R Holahan*

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2,Issue: 1
Page: 29-44
Authors: G. J. Marek

Conditioned Avoidance Response in the Development of New Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 358-370
Authors: M-L. G. Wadenberg

Reward Circuitry Dopaminergic Activation Regulates Food and Drug Craving Behavior

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 1158-1167
Authors: Kenneth Blum, Yijun Liu, Richard Shriner and Mark S. Gold

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 6
Page: 475-491
Authors: Kari A. Johnson, P. Jeffrey Conn and Colleen M. Niswender

Translational Pharmacology of a Putative Measure of Motor Impulsivity in Larval Zebrafish

Journal: Current Psychopharmacology
Volume: 5,Issue: 2
Page: 73-84
Authors: Matthew O. Parker and Caroline H. Brennan

Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease

Journal: Current Gene Therapy
Volume: 9,Issue: 5
Page: 375-388
Authors: Fredric p. Manfredsson, Michael S. Okun and Ronald J. Mandel

Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT1A, 5-HT2A and α1-Adrenergic Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 1
Page: 104-111
Authors: Tamara Romon, Anna M. Planas and Albert Adell

Pharmacological Aspects of (-)-Deprenyl

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 1
Page: 2017-2031
Authors: K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko

Catechol-O-methyltransferase, Cognition and Alzheimer's Disease

Journal: Current Alzheimer Research
Volume: 15,Issue: 5
Page: 408-419
Authors: Matea Nikolac Perkovic, Dubravka Svob Strac, Lucija Tudor, Marcela Konjevod, Gordana Nedic Erjavec and Nela Pivac*

Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1428-1434
Authors: Masato Asanuma and Ikuko Miyazaki

Understanding Gender Differences in Schizophrenia: A Review of the Literature

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 255-265
Authors: Rachel Taylor and Robyn Langdon

Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 5
Page: 590-594
Authors: Javad Golmirzaei, Hamidreza Mahboobi, Maryam Yazdanparast, Gohar Mushtaq, Mohammad A. Kamal and Enayatollah Hamzei

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 442-453
Authors: T. S. Shippenberg, A. LeFevour and V. I. Chefer

Can Increased Food Intake Improve Psychosis? A Brief Review and Hypothesis

Journal: Current Molecular Pharmacology
Volume: 1,Issue: 3
Page: 270-272
Authors: T. Treuer, J. Karagianis and V. P. Hoffmann

The Effects of Locus Coeruleus and Norepinephrine in Methamphetamine Toxicity

Journal: Current Neuropharmacology
Volume: 11,Issue: 1
Page: 80-94
Authors: Michela Ferrucci, Filippo S. Giorgi, Alessia Bartalucci, Carla L. Busceti and Francesco Fornai

Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 232-240
Authors: Li Lu, Fengqiao Li and Xiaomin Wang

Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3,Issue: 3
Page: 217-226
Authors: B. Dean and E. Scarr

Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 422-441
Authors: Shafiqur Rahman, Gretchen Y. Lopez-Hernandez, William A. Corrigall and Roger L. Papke

Application of Ligand SAR, Receptor Modeling and Receptor Mutagenesis to the Discovery and Development of a New class of 5-HT2A Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 6
Page: 575-598
Authors: Richard B. Westkaemper and Richard A. Glennon

Role of Neural Stem Cells in Parkinsons Disease

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 3
Page: 337-340
Authors: Rebeca Millan-Guerrero

Influence of Physical Immobilization of dsDNA on Carbon Based Matrices of Electrochemical Sensors

Journal: Current Pharmaceutical Analysis
Volume: 10,Issue: 1
Page: 20-29
Authors: Livia Alexandra Gugoasa, Raluca-Ioana Stefan-van Staden, Anton Alexandru Ciucu and Jacobus Frederick van Staden

Facilitative Effect of Serotonin1A Receptor Agonists on Cognition in Patients with Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 357-362
Authors: T. Sumiyoshi and Y. Higuchi

Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 183-189
Authors: Joseph T. Coyle, Guochuan Tsai and Donald C. Goff

“Speed” Warps Time: Methamphetamines Interactive Roles in Drug Abuse, Habit Formation, and the Biological Clocks of Circadian and Interval Timing

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 203-212
Authors: Lauren L. Williamson, Ruey-Kuang Cheng, Mikel Etchegaray and Warren H. Meck

Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 5024-5035
Authors: Jose Maria Pelayo-Teran, Paula Suarez-Pinilla, Nicholas Chadi and Benedicto Crespo-Facorro

Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1468-1486
Authors: Patricia H. Reggio

Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover

Journal: Current Drug Metabolism
Volume: 9,Issue: 7
Page: 622-627
Authors: G. Neurauter, K. Schrocksnadel, S. Scholl-Burgi, B. Sperner-Unterweger, C. Schubert, M. Ledochowski and D. Fuchs

Drugs and Aggression

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3,Issue: 1
Page: 40-49
Authors: Alberto A. Rasia-Filho, Marcia Giovenardi and Rosa M.M. de Almeida

Classical Neurotransmitters and Neuropeptides Involved in Major Depression in a Multi-neurotransmitter System: A Focus on Antidepressant Drugs

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 4853-4858
Authors: Felix-Martin Werner and R. Coveñas

The Progress of Selective Fluorescent Chemosensors by Boronic Acid

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 1
Page: 2621-2637
Authors: S. Huang, M. Jia, Y. Xie, J. Wang, W. Xu and H. Fang

Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 2065-2072
Authors: Zihang Pan, Joshua D. Rosenblat, Walter Swardfager and Roger S. McIntyre*

Cardiovascular Drug Therapy for Human Newborn: Review of Pharmacodynamic Data

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 0
Page: 1-15
Authors: Ebru Ergenekon, Hector Rojas-Anaya, Maria Carmen Bravo, Charalampos Kotidis, Liam Mahoney and Heike Rabe*

Fluparoxan: A Comprehensive Review of its Discovery, Adrenergic and CNS Activity and Treatment of Cognitive Dysfunction in Central Neurodegenerative Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 7
Page: 572-582
Authors: Alan D. Borthwick*

Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications

Journal: Current Drug Targets
Volume: 10,Issue: 1
Page: 1061-1068
Authors: Eliyahu Dremencov, Mostafa el Mansari and Pierre Blier

Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction

Journal: Current Drug Targets
Volume: 11,Issue: 4
Page: 440-449
Authors: Rafael Maldonado and Fernando Berrendero

Modulation of Eating by Central Catecholamine Systems

Journal: Current Drug Targets
Volume: 6,Issue: 2
Page: 191-199
Authors: Paul J. Wellman

Ketanserin and Spiperone as Templates for Novel Serotonin 5-HT2A Antagonists

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 6
Page: 539-558
Authors: Richard A. Glennon, Kamel Metwally, Malgorzata Dukat, Abd M. Ismaiel, Joseph De. Los Angeles, Jeffery Herndon, Milt Teitler and Nantaka Khorana

The Neuropharmacology of (-)-Stepholidine and its Potential Applications

Journal: Current Neuropharmacology
Volume: 5,Issue: 4
Page: 289-294
Authors: Kechun Yang, Guozhang Jin and Jie Wu

Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 2
Page: 200-208
Authors: Maria Antonietta Panaro and Antonia Cianciulli

The Neuropsychopharmacology of Pathological Gambling

Journal: Current Psychiatry Reviews
Volume: 8,Issue: 1
Page: 20-24
Authors: Kourosh Zakeri and Marc N. Potenza

Potential Novel Anxiolytic Drugs

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 3
Page: 3534-3546
Authors: D. Christmas, S. Hood and D. Nutt

Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 757-763
Authors: Maged M. Harraz and Solomon H. Snyder


Stimulating Effects of H1-Antagonists

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 2
Page: 2501-2509
Authors: Eef L. Theunissen, Annemiek Vermeeren, Eric F.P.M. Vuurman and Johannes G. Ramaekers

Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 3
Page: 371-380
Authors: Meijuan Zhang, Haiying Wang, Jinbing Zhao, Cong Chen, Rehana K. Leak, Yun Xu, Peter Vosler, Jun Chen, Yanqin Gao and Feng Zhang

Pharmacological Findings Contribute to the Understanding of the Main Physiological Mechanisms of Memory Retrieval

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 81-94
Authors: Daniela M. Barros, Luciana A. Izquierdo, Jorge H. Medina and Ivan Izquierdo

Prevention and Management of Ovarian Hyperstimulation Syndrome

Journal: Current Women`s Health Reviews
Volume: 6,Issue: 2
Page: 130-145
Authors: Botros Rizk and Christopher B. Rizk

Iron Chelators as Potential Therapeutic Agents for Parkinsons Disease

Journal: Current Bioactive Compounds
Volume: 4,Issue: 3
Page: 150-158
Authors: Carlos A. Perez, Yong Tong and Maolin Guo

Restless Leg Syndrome Associated with Olanzapine: A Case Series

Journal: Current Drug Safety
Volume: 5,Issue: 2
Page: 129-131
Authors: Shilpa Aggarwal, Seetal Dodd and Michael Berk

The Effects of Speech Therapy and Pharmacological Treatments on Voice and Speech in Parkinsons Disease: A Review of the Literature

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1359-1366
Authors: Geralyn M. Schulz

Cellular Mechanisms of Striatum-Dependent Behavioral Plasticity and Drug Addiction

Journal: Current Molecular Medicine
Volume: 2,Issue: 7
Page: 649-665
Authors: Stephania Fasano and Riccardo Brambilla

Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 5
Page: 547-560
Authors: Thomas R. Minor, Qingjun Huang and Alexis E. Witt

Neuropeptide Y: Role in Emotion and Alcohol Dependence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 2
Page: 181-195
Authors: R. Quirion, Y. Dumont and C. Carvajal

Noninvasive Genotyping of Dopamine Receptor D4 (DRD4) UsingNanograms of DNA From Substance-Dependent Patients

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 793-797
Authors: K. Boor, Z. Ronai, Z. Nemoda, P. Gaszner, M. Sasvari-Szekely, A. Guttman and H. Kalasz

Effects of Tetrahydroxystilbene Glucoside on Liver P450 Enzym e Expressions in Lipopolysaccharide-induced Dopamine Neuronal Dama ge Rats

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 8
Page: 904-909
Authors: Guo-Qing Wang, Yan-Zhen Zhou, Jia-Wei Tian, Jing-Shan Shi, Jie Liu and Feng Zhang*

Association Analysis of Genetic Variants of the Serotonin and Dopamine System-regulated Genes in Methamphetamine Abusers

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 4,Issue: 0
Page: 1-8
Authors: Jatuporn Namyen, Doungjai Buntup, Nanthawat Sitdhiraksa, Prapapun Chucharoen and Piyarat Govitrapong*

Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 72-82
Authors: Andres D. Ramirez and Sean M. Smith

Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness

Journal: Current Neuropharmacology
Volume: 15,Issue: 3
Page: 417-423
Authors: Francesca Demontis, Francesca Serra and Gino Serra

Editorial (Thematic Issue: Current Approaches for Antipsychotics in Drug Discovery: Hope Beyond the Dopamine D2 Receptor?)

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 3698-3699
Authors: Ronan Depoortère

Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 681-690
Authors: Luca Ferraro, Sarah Beggiato, Dasiel O. Borroto-Escuela, Laura Ravani, William T. O'Connor, Maria C. Tomasini, Andrea C. Borelli, Luigi F. Agnati, Tiziana Antonelli, Sergio Tanganelli and Kjell Fuxe

mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias

Journal: Current Neuropharmacology
Volume: 14,Issue: 5
Page: 481-493
Authors: Nicolas Morin, Marc Morissette, Laurent Grégoire and Thérèse Di Paolo

Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 707-715
Authors: Jack Bergman and Curtis G. Rheingold

Association of DRD2 TaqIA and DβH -1021C>T Gene Polymorphisms with Smoking Initiation and their Interaction with Serotonergic System Gene Polymorphisms

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 11,Issue: 2
Page: 110-117
Authors: Georgia Ragia, Maria Iordanidou, Efstathia Giannakopoulou, Anna Tavridou and Vangelis G. Manolopoulos

A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 0
Page: 1-15
Authors: Umberto Albert*, Donatella Marazziti, Gabriele Di Salvo, Francesca Solia, Gianluca Rosso and Giuseppe Maina

Nucleus Accumbens Dopamine and the Forebrain Circuitry Involved in Behavioral Activation and Effort-Related Decision Making: Implications for Understanding Anergia and Psychomotor Slowing in Depression

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 267-280
Authors: John D. Salamone, Merce Correa, Susana M. Mingote, Suzanne M. Weber and Andrew M. Farrar


The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 265-274
Authors: K. Uno, D. Nishizawa, S. Seo, K. Takayama, S. Matsumura, N. Sakai, K. Ohi, T. Nabeshima, R. Hashimoto, N. Ozaki, J. Hasegawa, N. Sato, F. Tanioka, H. Sugimura, K.-I.- Fukuda, S. Higuchi, H. Ujike, T. Inada, N. Iwata, I. Sora, M. Iyo, N. Kondo, M.-J. Won, N. Naruse, K. Uehara-Aoyama, M. Itokawa, M. Yamada, K. Ikeda, Y. Miyamoto and A. Nitta

Poly (Rhodamine B) and MWCNTs Composite Film for the Separation and Simultaneous Voltammetric Quantification of Tryptophan, Paracetamol, Uric Acid, Dopamine and Ascorbic Acid

Journal: Current Analytical Chemistry
Volume: 11,Issue: 2
Page: 87-95
Authors: Hayati Filik, Asiye Aslıhan Avan, Sevda Aydar and Re sat Apak

Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 4
Page: 437-457
Authors: Na Ye, Zilan Song and Ao Zhang

The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 2
Page: 3188-3210
Authors: M. Jorg, P.J. Scammells and B. Capuano

Therapeutic Potential of Monoamine Transporter Substrates

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 1845-1859
Authors: Richard B. Rothman and Michael H. Baumann

Catatonia: A Narrative Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 73-79
Authors: Michele Fornaro

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 278-288
Authors: Clelia Pellicano, Francesco E. Pontieri, Alessandra Fanciulli and Francesca R. Buttarelli

GCH1, BH4 and Pain

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 1
Page: 1728-1741
Authors: Alban Latremoliere and Michael Costigan

The Endocannabinoid System in Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2337-2346
Authors: Massimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Aroldo Rossi and Paolo Calabresi

Probiotics as an Adjuvant Therapy in Major Depressive Disorder

Journal: Current Neuropharmacology
Volume: 14,Issue: 8
Page: 952-958
Authors: Josipa Vlainić Vlainić, Jelena Šuran, Toni Vlainić and Antonella Letizia Vukorep

Recent Clinical Aspects of Eating Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 1
Page: 63-69
Authors: Anna Capasso, Claudio Petrella and Walter Milano

A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 2
Page: 2965-2976
Authors: O. M. Dean, M. van den Buuse, A.I. Bush, D.L. Copolov, F. Ng, S. Dodd and M. Berk

Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 153-163
Authors: E. Neuen-Jacob

Vasoactive Compounds in the Neonatal Period

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 2
Page: 4633-4639
Authors: P. Toth-Heyn and L. Cataldi

Neuroprotective Effects of Citrus reticulata in Scopolamine-Induced Dementia Oxidative Stress in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 4
Page: 684-690
Authors: Manal F. El-Khadragy, Ebtesam M. Al-Olayan and Ahmed E. Abdel Moneim

The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 454-467
Authors: E. A. Engleman, Z. A. Rodd, R. L. Bell and J. M. Murphy

PDZ Domain Protein-Protein Interactions: A Case Study with PICK1

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 3-20
Authors: Kumlesh K. Dev

Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 190-194
Authors: Y. Okahisa, M. Kodama, M. Takaki, T. Inada, N. Uchimura, M. Yamada, N. Iwata, M. Iyo, I. Sora, N. Ozaki and H. Ujike

Fibromyalgia: Mechanisms, Current Treatment and Animal Models

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 1
Page: 1613-1626
Authors: Jill-Desiree Brederson, Michael F. Jarvis, Prisca Honore and Carol S. Surowy

The Hydrogen Peroxide and its Importance in Alzheimers and Parkinsons Disease

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4,Issue: 4
Page: 279-285
Authors: M. Jimenez Del Rio and C. Velez-Pardo

Intrahypothalamic Administration of Modafinil Increases Expression of MAP-Kinase in Hypothalamus and Pons in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 463-467
Authors: Alwin Poot-Ake, Stephanie Mijangos-Moreno, Danielle Manjarrez-Martin, Ramses Jimenez-Moreno, Pedro R. Aquino-Hernandez, Elda Pacheco-Pantoja, Oscar Arias-Carrion, Andrea Sarro-Ramirez, Gloria Arankowsky-Sandoval and Eric Murillo-Rodriguez

Novel Micropelletization Technique: Highly Improved Dissolution, Wettability and Micromeritic Behavior of Domperidone

Journal: Current Drug Delivery
Volume: 3,Issue: 3
Page: 307-313
Authors: L. Prabakaran and Meenakshi Bajpai

Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 54-57
Authors: Nidhi Kaushal and Rae R. Matsumoto

New Molecules as Drug Candidates for the Treatment of Upper and Lower GI Tract Ulcers

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 2993-3001
Authors: Sandor Szabo and Ganna Tolstanova

Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents

Journal: Current Neuropharmacology
Volume: 4,Issue: 4
Page: 277-291
Authors: Yukihiko Shirayama and Shigeyuki Chaki

A Review of Neuropeptide and Neuroendocrine Dysregulation in Anorexia and Bulimia Nervosa

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 1
Page: 53-59
Authors: Ursula F. Bailer and Walter H. Kaye

Bupropion HCL and Sleep in Patients with Depression

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 2
Page: 123-128
Authors: Andrew D. Krystal, Michael E. Thase, Vivian L. Tucker and Elizabeth P. Goodale

Guide of Hypertensive Crisis Pharmacotherapy

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 17,Issue: 1
Page: 52-57
Authors: Priyanka Wani-Parekh*, Carlos Blanco-Garcia, Melissa Mendez and Debabrata Mukherjee

Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 872-879
Authors: Xiao Nan Lv, Zhu Jun Liu, Huan Jing Zhang and Chi Meng Tzeng

Serotonin and Obesity

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 2
Page: 89-100
Authors: A. Laviano and M. M. Meguid

Quick-Release Bromocriptine for Treatment of Type 2 Diabetes

Journal: Current Drug Delivery
Volume: 8,Issue: 5
Page: 511-516
Authors: Nasser Mikhail

The Abuse Liability and Therapeutic Potential of Drugs Evaluated for Cocaine Addiction as Predicted by Animal Models

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 21-46
Authors: Joshua A. Lile and Michael A. Nader

The Evolution of Histamine H3 Antagonists/Inverse Agonists

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 648-660
Authors: Evan P. Lebois, Carrie K. Jones and Craig W. Lindsley

The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 124-134
Authors: Isabel R. Schlaepfer, Nicole R. Hoft and Marissa A. Ehringer

Pharmacological Innovations for Posttraumatic Stress Disorder and Medication- Enhanced Psychotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 5645-5658
Authors: Boadie W. Dunlop, Erika Mansson and Maryrose Gerardi

A Review of Neuroprotective Agents

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 1
Page: 2383-2397
Authors: M. S. Levi and M. A. Brimble

The Neuroprotective Effects of Purslane (Portulaca oleracea) on Rotenone- Induced Biochemical Changes and Apoptosis in Brain of Rat

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 6
Page: 830-841
Authors: Ahmed E. Abdel Moneim

Treating Schizophrenia: Novel Targets for the Cholinergic System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 241-256
Authors: T.T. Money, E. Scarr, M. Udawela, A.S. Gibbons, W.J. Jeon, M.S. Seo and B. Dean

Targeting Nicotinic Receptors for Parkinsons Disease Therapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 651-658
Authors: Maryka Quik, Tanuja Bordia, Luping Huang and Xiomara Perez

Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 96-99
Authors: Y. Takamatsu, H. Shiotsuki, S. Kasai, S. Sato, T. Iwamura, N. Hattori and K. Ikeda

Association Analysis of the Adenosine A1 Receptor Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 137-142
Authors: > Kobayashi, Hiroshi Ujike, Nakao Iwata, Toshiya Inada, Mitsuhiko Yamada, Yoshimoto Sekine, Naohisa Uchimura, Masaomi Iyo, Norio Ozaki, Masanari Itokawa and Ichiro Sora

NSAID Use and the Risk of Parkinsons Disease

Journal: Current Drug Safety
Volume: 1,Issue: 3
Page: 223-225
Authors: Mahyar Etminan and Samy Suissa

Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 4,Issue: 3
Page: 220-238
Authors: Christina Hui, Brian Wardwell and Guochuan E. Tsai

New Perspectives in the Treatment of Cushings Syndrome

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 4
Page: 335-342
Authors: M. Labeur, E. Arzt, G. K. Stalla and M. Paez-Pereda

Conformationally Constrained Butyrophenones. Synthesis and Evaluation as Antipsychotics

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1,Issue: 1
Page: 43-62
Authors: Enrique Ravina and Christian F. Masaguer

Psychotic (Delusional) Major Depression in the Elderly: A Review

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 235-244
Authors: Rossetos Gournellis and Lefteris Lykouras

Parkinsons Disease: Genetics and Beyond

Journal: Current Neuropharmacology
Volume: 5,Issue: 2
Page: 99-113
Authors: N. N. Inamdar, D. K. Arulmozhi, A. Tandon and S. L. Bodhankar

Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 213-221
Authors: Jose Martinez-Raga, Carlos Knecht and Sonsoles Cepeda

Neurochemistry and Pharmacological Treatments: Where is the Field of Anorexia Nervosa Heading?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 35-43
Authors: Nicole C. Barbarich-Marsteller

Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 2
Page: 225-232
Authors: A. Holmes and M. R. Picciotto

Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 4
Page: 538-546
Authors: Alessandro Stefani, Enrica Olivola, Mario Stampanoni Bassi, Valerio Pisani, Paola Imbriani, Antonio Pisani and Mariangela Pierantozzi

Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate Receptors

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 109-122
Authors: Randal X. Moldrich and Philip M. Beart

Pharmacogenetics of Alcohol and Alcohol Dependence Treatment

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 1
Page: 2141-2148
Authors: Henry R. Kranzler and Howard J. Edenberg

The Evolution of Pharmacological Treatment for Parkinsons Disease

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3,Issue: 1
Page: 50-54
Authors: Quincy J. Almeida and H. Christopher Hyson

Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 3
Page: 4378-4391
Authors: M. M. Siddique and E. K. Tan

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

Journal: Current Neuropharmacology
Volume: 13,Issue: 3
Page: 395-406
Authors: Lurdes Tse, Alasdair M. Barr, Vanessa Scarapicchia and Fidel Vila-Rodriguez

Sigma Receptors and Cocaine Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 1128-1150
Authors: Sanju Narayanan, Christophe Mesangeau, Jacques H. Poupaert and Christopher R. McCurdy

Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors

Journal: Current Neuropharmacology
Volume: 1,Issue: 2
Page: 153-164
Authors: Vincenzo Di Matteo and Ennio Esposito

Recent Approaches to Novel Anti-Alzheimer Therapy

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 2
Page: 3167-3175
Authors: Carreiras M. C. and Marco J. L.

An Essential Role for Adenosine Signaling in Alcohol Abuse

Journal: Current Drug Abuse Reviews
Volume: 3,Issue: 3
Page: 163-174
Authors: Christina L. Ruby, Chelsea A. Adams, Emily J. Knight, Hyung Wook Nam and Doo-Sup Choi

Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets

Journal: Current Neuropharmacology
Volume: 1,Issue: 4
Page: 301-313
Authors: Jian Feng

Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 2594-2602
Authors: James M. Stone

Magnetic Resonance Imaging of Iron in Parkinsons Disease

Journal: Current Medical Imaging Reviews
Volume: 1,Issue: 1
Page: 43-48
Authors: Kazuo Abe and Tachio Hikita

The Face of Uncertainty Eats

Journal: Current Drug Abuse Reviews
Volume: 4,Issue: 3
Page: 174-181
Authors: Rebecca L.W. Corwin

Pathological Gambling: Neuropsychopharmacology and Treatment

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 67-85
Authors: Scott A. Bullock and Marc N. Potenza

Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease

Journal: Current Alzheimer Research
Volume: 7,Issue: 2
Page: 158-164
Authors: B. Borroni, C. Costanzi and A. Padovani

The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4,Issue: 4
Page: 331-347
Authors: A. P. Silva, S. Xapelli, E. Grouzmann and C. Cavadas

Obesity: Genetics, Behavior or a Combination of Both

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 4,Issue: 2
Page: 105-111
Authors: David Meyre, Philippe Boutin and Philippe Froguel

Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson s Disease

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 2673-2684
Authors: Ivan Carrera*, Lucia Fernandez-Novoa, Carolina Sampedro and Ramon Cacabelos

New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5 -Phosphate Decarboxylases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 3
Page: 226-244
Authors: Alessandro Paiardini, Giorgio Giardina, Giada Rossignoli, Carla Borri Voltattorni and Mariarita Bertoldi

Brain Angiotensin II Involvement in Chronic Mental Disorders

Journal: Protein & Peptide Letters
Volume: 24,Issue: 9
Page: 817-826
Authors: Osvaldo Martin Basmadjian, Victoria Belen Occhieppo, Natalia Andrea Marchese, Gustavo Baiardi and Claudia Bregonzio*

In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 17,Issue: 3
Page: 172-177
Authors: Saganuwan A. Saganuwan*

Hypersexuality As a Neuropsychiatric Disorder: The Neurobiology and Treatment Options

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-11
Authors: Hatta Sidi*, Muna Asiff, Jaya Kumar, Srijit Das, Nurul Hazwani Hatta and Cesar Alfonso

The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-10
Authors: Kanit Tha Deang, Hatta Sidi*, Hazli Zakaria, Raja Lope Adam, Srijit Das, Nurul Hazwani Hatta, Muhammad Hatta and Kok Wei Wee

Schizophrenia and Nicotine Dependence: What Psychopharmacological Treatment Options are Available for the Duo Perturbationes?

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-9
Authors: Yoong Mei Theng, Suzaily Wahab*, Noor Alaudin Wahab, Hatta Sidi and Srijit Das

Drug-Drug Interactions in Cocaine-users and their Clinical Implications

Journal: Current Drug Abuse Reviews
Volume: 10,Issue: 0
Page: 1-6
Authors: Luca Gallelli, Santo Gratteri, Antonio Siniscalchi*, Erika Cione, Sabrina Sirico, Paolo Seminara, Giovambattista De Sarro and Maria Cristina Caroleo

Neuroprotective Effects of Drug-Induced Therapeutic Hypothermia in Central Nervous System Diseases

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 1392-1398
Authors: Junwei Ma, Yibin Wang, Zhong Wang, Haiying Li, Zhimin Wang* and Gang Chen*

Sulfotransferase Inhibition: Potential Impact of Diet and Environmental Chemicals on Steroid Metabolism and Drug Detoxification

Journal: Current Drug Metabolism
Volume: 9,Issue: 4
Page: 269-275
Authors: R. M. Harris and R. H. Waring

Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1,Issue: 1
Page: 29-41
Authors: Christiaan B. Brink, Brian H. Harvey and Linda Brand

Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract

Journal: Current Neuropharmacology
Volume: 2,Issue: 1
Page: 91-102
Authors: A. A. Coutts

Transgenic Mouse Studies Reveal Substantial Roles for Opioid Receptors in the Rewarding Effects of Several Classes of Addictive Drugs

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 1
Page: 27-37
Authors: F. S. Hall and George R. Uhl

PEGylated Liposomes Incorporated with Nonionic Surfactants as an Apomorphine Delivery System Targeting the Brain: In Vitro Release and In Vivo Real-time Imaging

Journal: Current Nanoscience
Volume: 7,Issue: 2
Page: 191-199
Authors: Shu-Hui Hsu, Saleh A. Al-Suwayeh, Chih-Chieh Chen, Chen-Hsien Chi and Jia-You Fang

Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 132-136
Authors: Chihiro Ito

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinsons Disease and Other Motor Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 7
Page: 777-791
Authors: Massimo Pierucci, Salvatore Galati, Mario Valentino, Vincenzo Di Matteo, Arcangelo Benigno, Alessandro Pitruzzella, Richard Muscat and Giuseppe Di Giovanni

Design and Synthesis of Dopaminergic Agonists

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 2790-2825
Authors: Maria Soledad Matute, Rosa Matute and Pedro Merino

Transcranial Brain Stimulation in Schizophrenia: Targeting Cortical Excitability, Connectivity and Plasticity

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 405-413
Authors: A. Hasan, P. Falkai and T. Wobrock

Methylone and Monoamine Transporters: Correlation with Toxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 58-62
Authors: Chiharu Sogawa, Norio Sogawa, Kazumi Ohyama, Ruri Kikura-Hanajiri, Yukihiro Goda, Ichiro Sora and Shigeo Kitayama

Therapeutic Strategies in Parkinsons Disease

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2,Issue: 2
Page: 135-147
Authors: Muchukunte M.S. Bharath

Mechanisms of Sleep-Wake Cycle Modulation

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 4
Page: 245-253
Authors: Eric Murillo-Rodriguez, Oscar Arias-Carrion, Katya Sanguino-Rodriguez, Mauricio Gonzalez-Arias and Reyes Haro

Serotonin Receptor and Transporter Ligands - Current Status

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 9
Page: 999-1034
Authors: Seung Jun Oh, Hyun-Joon Ha, Dae Yoon Chi and Hee Kyung Lee

Clozapine and Olanzapine but not Risperidone Impair the Pre-Frontal Striatal System in relation to Egocentric Spatial Orientation in a Y-Maze

Journal: Current Neurovascular Research
Volume: 4,Issue: 4
Page: 235-239
Authors: Cibele Canal Castro, Eleonora Araujo Dos Reis-Lunardelli, Werner J. Schmidt, Adriana Simon Coitinho and Ivan Izquierdo


Classical Neurotransmitters and Neuropeptides Involved in Generalized Epilepsy: A Focus on Antiepileptic Drugs

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 4933-4948
Authors: F.-M. Werner and R. Covenas

Autonomic Nervous System Alterations in Rett Syndrome

Journal: Current Pediatric Reviews
Volume: 5,Issue: 3
Page: 160-168
Authors: Maurizio Acampa and Francesca Guideri

Prevention of Contrast Induced Nephropathy

Journal: Current Drug Therapy
Volume: 2,Issue: 1
Page: 3-9
Authors: Jeffrey W.H. Fung, Cheuk C. Szeto, Leo C.C. Kum and Cheuk M. Yu

Molecular Mapping in the CNS

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 1
Page: 1547-1570
Authors: Margaret G. Wong, Benjamin G. Tehan and Edward J. Lloyd

Inflammation and Age-Related Iron Accumulation in F344 Rats

Journal: Current Aging Science
Volume: 1,Issue: 2
Page: 112-121
Authors: Randy L. Hunter, Mei Liu, Dong Young Choi, Wayne A. Cass and Guoying Bing

Recent Patents on Pharmacotherapy for Alcoholism

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1,Issue: 2
Page: 175-206
Authors: Jozsef Nagy

Neonatal Environment and Neuroendocrine Programming of the Peripheral Respiratory Control System

Journal: Current Pediatric Reviews
Volume: 2,Issue: 3
Page: 199-208
Authors: Aida Bairam, Richard Kinkead and Vincent Joseph

Effects of Antipsychotics on the BDNF in Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 345-350
Authors: T. L. Huang



Journal: Current Drug Metabolism
Volume: 14,Issue: 9
Page: 989-993
Authors: Yan Liu, Yan-Wu Li, Ya-Lan Tang, Xin Liu, Jun-Hao Jiang, Qing-Gen Li and Jian-Yong Yuan

The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 14,Issue: 3
Page: 169-181
Authors: Etual Espinosa, Claudia Ramirez and Moises Mercado

Pharmacological Treatments for Cocaine Dependence: Is There Something New?

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 1359-1368
Authors: Laurent Karila, Michel Reynaud, Henri-Jean Aubin, Benjamin Rolland, Dewi Guardia, Olivier Cottencin and Amine Benyamina

Medicinal Chemistry of A2A Adenosine Receptor Antagonists

Journal: Current Topics in Medicinal Chemistry
Volume: 3,Issue: 4
Page: 403-411
Authors: Barbara Cacciari, Giorgia Pastorin and Giampiero Spalluto

Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System

Journal: Current Neurovascular Research
Volume: 7,Issue: 1
Page: 32-38
Authors: Suw Young Ly, Hwa Jin Heo and Min Jung Kim

The Role of Extracellular Adenosine in Chemical Neurotransmission in the Hippocampus and Basal Ganglia: Pharmacological and Clinical Aspects

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1034-1046
Authors: Beata Sperlagh and E. Sylvester Vizi

Bivalent Ligands for G Protein-Coupled Receptors

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 1
Page: 2015-2020
Authors: William S. Messer and Jr.

Basic Sleep Mechanisms: An Integrative Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 38-54
Authors: Eric Murillo-Rodriguez, Oscar Arias-Carrion, Abraham Zavala-Garcia, Andrea Sarro-Ramirez, Salvador Huitron-Resendiz and Gloria Arankowsky-Sandoval

New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 3
Page: 343-358
Authors: Alessandro Serretti, Diana De Ronchi, Cristina Lorenzi and Domenico Berardi

Current Advances in the Treatment of Parkinsons Disease with Stem Cells

Journal: Current Neurovascular Research
Volume: 4,Issue: 2
Page: 99-109
Authors: Katarzyna A. Trzaska and Pranela Rameshwar

Gene Therapy for Parkinsons Disease: Progress and Challenges

Journal: Current Gene Therapy
Volume: 5,Issue: 1
Page: 71-80
Authors: Qin Chen, Yi He and Keyi Yang

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 47-60
Authors: Piotr Tybura, Beata Trzesniowska-Drukala and Jerzy Samochowiec

Synthesis of [18F]Fallypride in a Micro-Reactor: Rapid Optimization and Multiple-Production in Small Doses for Micro-PET Studies

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 1
Page: 49-55
Authors: Shuiyu Lu, Anthony M. Giamis and Victor W. Pike

Promising Medications for Cocaine Dependence Treatment

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6,Issue: 2
Page: 146-160
Authors: Lorenzo Somaini, Claudia Donnini, Maria A. Raggi, Mario Amore, Roberto Ciccocioppo, Maria A. Saracino, Marsida Kalluppi, Marco Malagoli, Maria L. Gerra and Gilberto Gerra

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 692-699
Authors: Ryan Bachtell, Mark R. Hutchinson, Xiaohui Wang, Kenner C. Rice, Steven F. Maier and Linda R. Watkins

Ovarian Hyperstimulation Syndrome: The Best Approaches for Preven-tion and Treatment: A Mini-Review

Journal: Current Women`s Health Reviews
Volume: 3,Issue: 1
Page: 49-54
Authors: Massimo Manno, Francesco Tomei, Alessandro Fasciani and Mauro Costa

Computer Prediction of Cardiovascular and Hematological Agents by Statistical Learning Methods

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5,Issue: 1
Page: 11-19
Authors: X. Chen, H. Li, C. W. Yap, C. Y. Ung, L. Jiang, Z. W. Cao, Y. X. Li and Y. Z. Chen

Inflammatory Process in Parkinsons Disease: Role for Cytokines

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 8
Page: 999-1016
Authors: T. Nagatsu and M. Sawada

Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Choose the Appropriate Antipsychotic Drug?

Journal: Current Drug Therapy
Volume: 8,Issue: 2
Page: 132-143
Authors: Felix-Martin Werner and Rafael Covenas

Half a Century of l-DOPA

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 880-893
Authors: Maria Angeles Mena, Maria Jose Casarejos, Rosa Maria Solano and Justo Garcia de Yebenes

Investigational Positive Inotropic Agents for Acute Heart Failure

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 3
Page: 193-205
Authors: Juan Tamargo, Ricardo Caballero, Ricardo Gomez, Adriana Barana, Irene Amoros and Eva Delpon

Current and Future Therapeutic Strategies for Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 3
Page: 3968-3976
Authors: Tiago Fleming Outeiro and Joaquim Ferreira

Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 3
Page: 243-255
Authors: Thomas E. Wooters, Rick A. Bevins and Michael T. Bardo

Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 5
Page: 589-609
Authors: Amteshwar Singh Jaggi and Nirmal Singh

Pharmacogenomics in Psychiatry: Implications for Practice

Journal: Recent Patents on Biotechnology
Volume: 8,Issue: 2
Page: 152-159
Authors: Thea R. Moore, Angela M. Hill and Siva K. Panguluri

Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8,Issue: 1
Page: 30-37
Authors: Domenico De Berardis, Michele Fornaro, Nicola Serroni, Stefano Marini, Monica Piersanti, Marilde Cavuto, Alessandro Valchera, Monica Mazza, Gabriella Girinelli, Felice Iasevoli, Giampaolo Perna, Giovanni Martinotti and Massimo Di Giannantonio

Gastrodia Elata Bl Attenuates Methamphetamine-Induced Dopaminergic Toxicity Via Inhibiting Oxidative Burdens

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 118-121
Authors: E.-J. Shin, J.-H. Bach, T.-T. L. Nguyen, X.-K. T. Nguyen, B.-D. Jung, K.-W. Oh, M. J. Kim, S. K. Ko, C. G. Jang, S. F. Ali and H.-C. Kim

GPE and GPE Analogues as Promising Neuroprotective Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 13-23
Authors: I. Cacciatore, C. Cornacchia, L. Baldassarre, E. Fornasari, A. Mollica, A. Stefanucci and F. Pinnen

COMT as a Drug Target for Cognitive Functions and Dysfunctions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 209-221
Authors: Diego Scheggia, Sara Sannino, Maria Luisa Scattoni and Francesco Papaleo

Effect of Acute Administration of 8-(Trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine Hydrochloride (TC-2153) on Biogenic Amines Metabolism in Mouse Brain

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 1
Page: 833-836
Authors: Elizabeth A. Kulikova, Ekaterina Y. Bazhenova, Nina K. Popova, Tatyana M. Khomenko, Konstantin P. Volcho, Nariman F. Salakhutdinov and Alexander V. Kulikov

Paliperidone: A Clinical Review

Journal: Current Drug Therapy
Volume: 4,Issue: 1
Page: 7-11
Authors: Ben Green

Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 1
Page: 1430-1449
Authors: V. Di Marzo and L. De Petrocellis

Pharmacological Support of Neurorehabilitation

Journal: Current Drug Therapy
Volume: 1,Issue: 1
Page: 17-22
Authors: Burkhard Pleger and Patrick Ragert

Nitric Oxide (NO) System in Major Depression: Studies on NO Synthase Inhibitors as Antidepressant Agents

Journal: Current Enzyme Inhibition
Volume: 12,Issue: 1
Page: 40-48
Authors: Ashish Dhir and Shrinivas K. Kulkarni

Catecholamines: Physiological Immunomodulators During Health and Illness

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 1
Page: 1979-1989
Authors: Reiner Oberbeck

Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 7
Page: 796-840
Authors: Helton J. Reis, Cristina Guatimosim, Maryse Paquet, Magda Santos, Fabiola M. Ribeiro, Arthur Kummer, Grace Schenatto, Joao V. Salgado, Luciene B. Vieira, Antonio L. Teixeira and Andras Palotas

The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 371-377
Authors: Akihiro Takano

Bulimia Nervosa and Alcohol Use Disorder: Evidence for Shared Etiology and Neurobiology

Journal: Current Psychiatry Reviews
Volume: 8,Issue: 1
Page: 69-81
Authors: Zeynep Yilmaz, Allan S. Kaplan and Laurie A. Zawertailo

An Inflammatory Pathomechanism for Parkinsons Disease?

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 5
Page: 591-602
Authors: Christophe Wersinger and Anita Sidhu

The Pathophysiological Role of the Serotonergic System in Tourette Syndrome

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 4
Page: 271-276
Authors: Kirsten R. Muller-Vahl

Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 4
Page: 638-646
Authors: Ahmed E. Abdel Moneim

Non-Classical Drug Metabolism Enzymes: The Curious Case of Phenylalanine 4-Monooxygenase

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 6
Page: 405-412
Authors: G. B. Steventon and S. C. Mitchell

Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 3
Page: 303-327
Authors: Zheng-Xiong Xi and Eliot L. Gardner

The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries

Journal: Current Neurovascular Research
Volume: 6,Issue: 3
Page: 171-180
Authors: Celine Ullrich and Christian Humpel

A Novel Prion Protein-Tyrosine Hydroxylase Interaction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 5
Page: 896-908
Authors: Mattia Vicario, Adriana Zagari, Vincenzo Granata, Francesca Munari, Stefano Mammi, Luigi Bubacco, Stephen D. Skaper and Alessandro Negro

Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction

Journal: Current Neuropharmacology
Volume: 1,Issue: 2
Page: 165-174
Authors: Emmanuel Valjent, Denis Herve, Jocelyne Caboche and Jean-Antoine Girault

Synthesis and Pain Perception of New Analogues of Phencyclidine in NMRI Male Mice

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 1
Page: 64-71
Authors: Abbas Ahmadi, Mohsen Khalili, Sara Marami, Afsane Ghadiri and Babak Nahri-Niknafs

New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 7
Page: 772-792
Authors: Roberto Mandrioli*, Michele Protti and Laura Mercolini

Three Dimensional Analysis of SPECT Images for Diagnosing Early Parkinson s Disease Using Radial Basis Function Kernel- Extreme Learning Machine

Journal: Current Medical Imaging Reviews
Volume: 14,Issue: 0
Page: 1-10
Authors: S. Anita and P. Aruna Priya*

Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 2550-2559
Authors: O. D. Howes, A. Egerton, V. Allan, P. McGuire, P. Stokes and S. Kapur

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 148-157
Authors: Yukihiro Ohno

SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 471-483
Authors: Hanna Mannell and Florian Krotz

Chronic Effects of Cocaine on Dopaminergic and Serotonergic Systems of Rats

Journal: Current Molecular Imaging (Discontinued)
Volume: 4,Issue: 1
Page: 43-52
Authors: Chun-Kai Fang, Hui-Yen Chuang, Wei-Hsun Wang, Ren-Shyun Liu, Shyh-Jen Wang and Jeng-Jong Hwang

Neurochemical Substrates of MDMA Reward: Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-induced CPP

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 4
Page: 7050-7064
Authors: C. Roger-Sánchez, M. A. Aguilar, C. Manzanedo, J. Miñarro and M. Rodríguez-Arias

Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity

Journal: Current Drug Targets
Volume: 2,Issue: 4
Page: 353-370
Authors: Jason C. G. Halford

Disorders of Tetrahydrobiopterin Metabolism and their Treatment

Journal: Current Drug Metabolism
Volume: 3,Issue: 2
Page: 123-131
Authors: H. Shintaku

Signal Transduction via Cannabinoid Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 6
Page: 422-431
Authors: George D. Dalton, Caroline E. Bass, Cynthia G. Van Horn and Allyn C. Howlett



Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 369-380
Authors: Mohd Shahnawaz Khan, Shams Tabrez, Medha Priyadarshini, Shubha Priyamvada and Mohd M. Khan

The Control of Male Sexual Responses

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 2
Page: 4341-4356
Authors: Frederique Courtois, Serge Carrier, Kathleen Charvier, Pierre A. Guertin and Nicolas Morel Journel

Ether and Carbamate Derivatives of 3-quinuclidinol and 3- hydroxymethylquinuclidine: Synthesis and Evaluation as Nicotinic Ligands

Journal: Medicinal Chemistry
Volume: 12,Issue: 6
Page: 574-584
Authors: Sivakumar Annadurai, Min Zhang, Jerome L. Gabriel, Merouane Bencheriff and Daniel J. Canney

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 8
Page: 771-785
Authors: Craig W. Lindsley, William D. Shipe, Scott E. Wolkenberg, Cory R. Theberge, David L. Williams Jr., Cyrille Sur and Gene G. Kinney

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 344-357
Authors: Lee A. Dawson and Paul W. Smith

Glutamate-regulated Behavior, Transmitter Release, Gene Expression and Addictive Plasticity in the Striatum: Roles of Metabotropic Glutamate Receptors

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 1-20
Authors: John Q. Wang, Limin Mao, Nikhil K. Parelkar, Qingsong Tang, Zhenguo Liu, Shazia Sarwar and Eun Sang Choe

Role of the Central Cholinergic System in the Therapeutics of Schizophrenia

Journal: Current Neuropharmacology
Volume: 6,Issue: 3
Page: 286-292
Authors: Alvin V. Terry and Jr.

Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 52-64
Authors: Walter Milano, Cosimo Walter D'Acunto, Michele De Rosa, Michela Festa, Luca Milano, Claudio Petrella and Anna Capasso

COMT Implication in Cognitive and Psychiatric Symptoms in Chromosome 22q11 Microdeletion Syndrome: A Selective Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 273-281
Authors: Marco Armando, Francesco Papaleo and Stefano Vicari

The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs

Journal: Current Drug Targets
Volume: 14,Issue: 1
Page: 1277-1294
Authors: Gaël Quesseveur, Alain M. Gardier and Bruno P. Guiard

GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5,Issue: 3
Page: 277-291
Authors: P. Dasgupta

Metoclopramide as an Analgesic in Severe Migraine Attacks: An Open, Single-blind, Parallel Control Study

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6,Issue: 2
Page: 141-145
Authors: Gabriel Salazar, Marta Fragoso, Luis Vergez, Piera Sergio and Denisse Cuello

The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 1151-1156
Authors: Nurulain T. Zaveri



Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 913-948
Authors: Mario Di Napoli

mGlu5 Receptors: Neuroanatomy, Pharmacology, and Role in Drug Addiction

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 197-214
Authors: M. Foster Olive

Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Journal: Current Psychiatry Reviews
Volume: 12,Issue: 3
Page: 278-290
Authors: James C. Nelson, Peter Zhang, Aleksandar Skuban, Mary Hobart, Catherine Weiss, Emmanuelle Weiller and Michael E. Thase

Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 2525-2538
Authors: Stefano Govoni, Elisa Mura, Stefania Preda, Marco Racchi, Cristina Lanni, Massimo Grilli, Stefania Zappettini, Alessia Salamone, Guendalina Olivero, Anna Pittaluga and Mario Marchi

Modulation of 3,4-Methylenedioxymethamphetamine Effects by Endocannabinoid System

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 4
Page: 7081-7091
Authors: Olga Valverde and Marta Rodríguez-Árias

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 5
Page: 488-501
Authors: Richard B. Mailman and Vishakantha Murthy

Central Nervous System Agents Used as Trypanosoma cruzi Infection Chemotherapy: Phenothiazines and Related Compounds

Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 2,Issue: 4
Page: 323-333
Authors: P. Paglini-Oliva and H. W. Rivarola

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 1
Page: 1612-1632
Authors: Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, Branko Turkovic, Dinko Stancic Rokotov, Luka Brcic, Marko Sever, Robert Klicek, Bozo Radic, Domagoj Drmic, Spomenko Ilic, Danijela Kolenc, Hrvoje Vrcic and Bozidar Sebecic

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 1
Page: 1647-1674
Authors: Karl Ebner, Simone B. Sartori and Nicolas Singewald

What is the Evidence for the use of Adrenaline in the Treatment of Neonatal Hypotension?

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 50-98
Authors: Liam Mahoney, David Crook, Kerstin N. Walter, Ella Sherman and Heike Rabe

The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 3
Page: 5144-5162
Authors: Domenico De Berardis, Laura Orsolini, Felice Iasevoli, Emiliano Prinzivalli, Andrea de Bartolomeis, Nicola Serroni, Monica Mazza, Alessandro Valchera, Michele Fornaro, Roberta Vecchiotti, Alessandro Carano, Gianna Sepede, Federica Vellante, Ilaria Matarazzo, Maurizio Pompili, Giampaolo Perna, Chiara Conti, Cristina Segura-García, Giovanni Martinotti and Massimo Di Giannantonio

Ca2+-Myristoyl Switch in Neuronal Calcium Sensor-1: A Role of C-Terminal Segment

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 437-451
Authors: Viktoriia E. Baksheeva, Aliya A. Nazipova, Dmitry V. Zinchenko, Marina V. Serebryakova, Ivan I. Senin, Sergei E. Permyakov, Pavel P. Philippov, Yi Li, Andrey A. Zamyatnin, Evgeni Y. Zernii and Gjumrakch Aliev

Sensory-Motor Integration in the Medial Medulla

Journal: Current Neuropharmacology
Volume: 3,Issue: 2
Page: 115-143
Authors: Yuan-Yang Lai and Jerome M. Siegel

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

Journal: Current Neuropharmacology
Volume: 3,Issue: 1
Page: 9-34
Authors: Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration

Journal: Current Neuropharmacology
Volume: 10,Issue: 1
Page: 64-71
Authors: Anand Kumar Singh, Manindra Nath Tiwari, Om Prakash and Mahendra Pratap Singh

Pharmacological Strategies for the Prevention of Acute Kidney Injury Following Cardiac Surgery: An Overview of Systematic Reviews

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 3
Page: 5484-5488
Authors: Nishith N. Patel and Gianni D. Angelini

On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 2
Page: 2305-2320
Authors: M. A. Mena, J. A. Rodriguez-Navarro, R. Ros and J. G. de Yebenes



Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 3
Page: 280-291
Authors: Michael Soyka and Susanne Rosner

Schizophrenia: Genesis, Receptorology and Current Therapeutics

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 5
Page: 521-548
Authors: B. Capuano, I. T. Crosby and E. J. Lloyd

The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinsons Disease

Journal: Current Clinical Pharmacology
Volume: 2,Issue: 3
Page: 234-243
Authors: Soo-Peang Khor and Ann Hsu

Computer-Aided Drug Design for Typical and Atypical Antipsychotic Drugs: A Review of Application of QSAR and Combinatorial Chemistry Methods - Tools for New Antipsychotics Design

Journal: Current Computer-Aided Drug Design
Volume: 1,Issue: 4
Page: 347-364
Authors: S. Avram, A.- L. Milac and M. L. Flonta

Animal Models for Obsessive-Compulsive Disorder

Journal: Current Neuropharmacology
Volume: 2,Issue: 2
Page: 169-181
Authors: J. Man, A. L. Hudson, D. Ashton and D. J. Nutt

Multiple Faceted Roles of Cocaine in Potentiation of HAND

Journal: Current HIV Research
Volume: 14,Issue: 5
Page: 412-416
Authors: Yu Cai, Lu Yang, Shannon Callen and Shilpa Buch

3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 143-148
Authors: W. J. Burke

Effect of Withania somnifera Supplementation on Rotenone-Induced Oxidative Damage in Cerebellum and Striatum of the Male Mice Brain

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 43-56
Authors: Mallaya Jayawanth Manjunath and Muralidhara

Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 4
Page: 477-488
Authors: Sajjad Karim, Mohammad A. Kamal, Zafar Iqbal, Shakeel A. Ansari, Mahmood Rasool, Mohammed H. Al-Qahtani, Gazi Damanhouri and Zeenat Mirza

Thiophene Scaffold as Prospective Central Nervous System Agent: A Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 158-164
Authors: Aakash Deep, Balasubramanian Narasimhan, Swati Aggarwal, Dhirender Kaushik and Arun K. Sharma

Addictive Influences and Stress Propensity in Heavy Internet Users: A Proposition for Information Overload Mediated Neuropsychiatric Dysfunction

Journal: Current Psychiatry Reviews
Volume: 13,Issue: 4
Page: 293-300
Authors: Ashutosh Kumar, Muneeb A. Faiq*, Sada Nand Pandey, Vikas Pareek, Sankat Mochan, Pavan Kumar, Subrahamanyam Dantham and Khursheed Raza*

Neuromodulation of Spinal Locomotor Networks in Rodents

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 1741-1752
Authors: Manuel Diaz-Ríos*, Pierre A. Guertin and Marla Rivera-Oliver

Cyclodextrins Based Electrochemical Sensors for Biomedical and Pharmaceutical Analysis

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 2
Page: 2359-2391
Authors: Joanna Lenik*

Intramuscular Route of Administration Increases Potency in Eliciting Cocaine-Induced Behavioral Sensitization

Journal: Current Psychopharmacology
Volume: 6,Issue: 1
Page: 36-42
Authors: Beth A. Rice, Raza Tariq and Chana K. Akins*

Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 20,Issue: 6
Page: 492-509
Authors: Muthusamy Ramesh , Yussif M. Dokurugu, Michael D. Thompson and Mahmoud E. Soliman*

New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 20,Issue: 6
Page: 461-473
Authors: Begum Evranos-Aksoz *, Gulberk Ucar, Sadik Taskin Tas, Erkan Aksoz, Kemal Yelekci, Acelya Erikci, Yildirim Sara and Alper Bektas Iskit

Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 9
Page: 1027-1038
Authors: Zeenat Mirza* and Nisreen Rajeh

Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 4012-4028
Authors: Predrag Sikiric*, Sven Seiwerth, Rudolf Rucman, Domagoj Drmic, Mirjana Stupnisek, Antonio Kokot, Marko Sever, Ivan Zoricic, Zoran Zoricic, Lovorka Batelja, Tihomil Ziger, Kresimir Luetic, Josipa Vlainic, Zarko Rasic and Martina Lovric Bencic

New Trends in the Treatment of Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16,Issue: 8
Page: 900-906
Authors: Herbert Y. Meltzer*

The Role of Atypical Antipsychotics in Sexuality: Road to Recovery in Schizophrenia

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-10
Authors: Raja Lope Adam, Hatta Sidi*, Marhani Midin, Hazli Zakaria, Srijit Das and Khairi Che Mat

The Bio-Psycho-Social Dimension in Women s Sexual Desire: Argumentum ad novitatem

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-12
Authors: Nur Syazwani Roslan, Nik Ruzyanei Nik Jaafar, Hatta Sidi*, Najwa Baharuddin, Jaya Kumar, Srijit Das and Nik Hazlina Nik Hussein

Subduing the Green-eyed Monster: Bridging the Psychopharmacological and Psychosocial Treatment Perspective in Understanding Pathological Jealousy

Journal: Current Drug Targets
Volume: 18,Issue: 0
Page: 1-9
Authors: Farah Deena Abdul Samad, Hatta Sidi*, Jaya Kumar, Srijit Das, Marhani Midin and Nurul Hazwani Hatta

The Behavioral Profile of Methylenedioxypyrovalerone (MDPV) and ? pyrrolidinopentiophenone (PVP) - A Systematic Review

Journal: Current Drug Abuse Reviews
Volume: 10,Issue: 0
Page: 1-5
Authors: Cornel N. Stanciu*, Thomas M. Penders, Samantha A. Gnanasegaram, Elvin Pirapakaran, Juvraj S. Padda and Jeeven S. Padda

Are There Differences in Catecholamine Levels in Body Fluids of Individuals with and Without Sleep Bruxism? A Systematic Review

Journal: Current Chemical Biology
Volume: 11,Issue: 0
Page: 1-9
Authors: Claudia Tavares-Silva , Daniele Masterson, Lucianne Cople Maia and Andrea Fonseca-Goncalves*

Natural Products Combating Neurodegeneration: Parkinson s Disease

Journal: Current Drug Metabolism
Volume: 18,Issue: 1
Page: 50-61
Authors: Md. Solayman, Md. Asiful Islam, Fahmida Alam, Md. Ibrahim Khalil, Mohammad Amjad Kamal and Siew Hua Gan

Development and Characterization Pulsatile Microspheres of Nifedipine for Hypertension

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 11,Issue: 1
Page: 67-76
Authors: Rahul Taneja* and Ghanshyam D. Gupta

Insilico Analysis of Post-Translational Modifications in DRD2 Receptor Protein in Schizophrenic Patients

Journal: Current Proteomics
Volume: 14,Issue: 1
Page: 53-57
Authors: Afshan Zeeshan Wasti, Nikhat Ahmed, Hajira Karim, Amna Ahmed and Ayesha Khan

PET Imaging of Norepinephrine Transporters

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 3
Page: 3831-3845
Authors: Yu-Shin Ding, Kuo-Shyan Lin and Jean Logan

Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System

Journal: Current Protein & Peptide Science
Volume: 6,Issue: 4
Page: 373-385
Authors: Reiner Fischer-Colbrie, Rudolf Kirchmair, Christian M. Kahler, Christian J. Wiedermann and Alois Saria

The CNS Melanocortin System: A Biological Weapon Against the Threat of Obesity

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 3
Page: 201-215
Authors: M. M. Hagan, P. C. Chandler and P. K. Wauford

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 7
Page: 1311-1320
Authors: Pierre Chue

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 3-19
Authors: M. D. Berry

The Physiology of Learning and Memory: Role of Peptides and Stress

Journal: Current Protein & Peptide Science
Volume: 5,Issue: 6
Page: 457-473
Authors: M. A. Gulpinar and B. C. Yegen

Development of Radioligands for Imaging of Brain Norepinephrine Transporters In Vivo with Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1806-1816
Authors: Magnus Schou, Victor W. Pike and Christer Halldin

Neurotoxicity of Ecstasy (MDMA): An Overview

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 5
Page: 460-469
Authors: Sumit Sarkar and Larry Schmued

The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation

Journal: Current Drug Discovery Technologies
Volume: 6,Issue: 3
Page: 171-185
Authors: Jose Juan Escobar-Chavez, Virginia Merino, Miriam Lopez-Cervantes, Isabel Marlen Rodriguez-Cruz, David Quintanar-Guerrero and Adriana Ganem-Quintanar

Molecular Genetics of Alcohol Dependence and Related Endophenotypes

Journal: Current Genomics
Volume: 9,Issue: 7
Page: 444-451
Authors: Yann L. Strat, Nicolas Ramoz, Gunter Schumann and Philip Gorwood

L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinsons Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 305-320
Authors: Sylvia Navailles, Manolo Carta, Martin Guthrie and Philippe De Deurwaerdere

Pharmacology of Motor and Somatosensory Skills in Humans

Journal: Current Neuropharmacology
Volume: 3,Issue: 2
Page: 145-156
Authors: Burkhard Pleger, Martin Tegenthoff, Hubert Dinse, Patrick Ragert and Peter Schwenkreis

Fenoldopam in Cardiovascular Surgery: A Review

Journal: Vascular Disease Prevention
Volume: 5,Issue: 4
Page: 223-226
Authors: Giovanni Landoni, Francesco A. Garozzo, Anna Mizzi and Alberto Zangrillo

Synthesis and Pharmacological Activities of Amine-Boranes

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 1
Page: 1995-2010
Authors: Bruce S. Burnham

An Update on the Extraneuronal Monoamine Transporter (EMT): Characteristics, Distribution and Regulation

Journal: Current Drug Metabolism
Volume: 4,Issue: 4
Page: 313-318
Authors: F. Martel and I. Azevedo

The Pharmacology of Human Appetite Expression

Journal: Current Drug Targets
Volume: 5,Issue: 3
Page: 221-240
Authors: Jason C.G. Halford, Gillian D. Cooper and Terence M. Dovey

Use of Dopaminergic Agents in the Treatment-Resistant Depression

Journal: Current Psychopharmacology
Volume: 4,Issue: 2
Page: 70-75
Authors: Lorena Rodríguez-Bores, Mónica Flores-Ramos and Rafael Campuzano

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 6
Page: 512-523
Authors: L. W. Chen, K. K.L. Yung, Y. S. Chan, D. K.Y. Shum and J. P. Bolam

Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 180-192
Authors: Stefan M. Brudzynski

The Role of N-Methyl-D-Aspartate Receptor - Mediated Neurotransmission in Attention Deficit (Hyperactivity) Disorder (ADHD/ADD)

Journal: Current Psychopharmacology
Volume: 3,Issue: 3
Page: 184-194
Authors: Andrea R. Durrant and Uriel Heresco-Levy

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 3359-3366
Authors: Nicolas Simon, Benjamin Rolland and Laurent Karila

Research and Development of Nuclear Molecular Imaging in Taiwan

Journal: Current Medical Imaging Reviews
Volume: 5,Issue: 4
Page: 242-254
Authors: Lie-Hang Shen, Yu-Chin Tseng, Chih-Hsien Chang and Chia-Chieh Chen

Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome

Journal: Current Pharmacogenomics
Volume: 4,Issue: 2
Page: 113-119
Authors: Chiaki Kawanishi, Ikuko Kishida, Taku Furuno, Daiji Kato and Leif Bertilsson

Hypericin - The Facts About a Controversial Agent

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 2
Page: 233-253
Authors: A. Kubin, F. Wierrani, U. Burner, G. Alth and W. Grunberger

Addictions and Stress: Clues for Cocaine Pharmacotherapies

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 4
Page: 7065-7080
Authors: R. Picetti, S. D. Schlussman, Y. Zhou, B. Ray, E. Ducat, V. Yuferov and M. J. Kreek

Stimulant Drug Effects on Attention Deficit/Hyperactivity Disorder: A Review of the Effects of Age and Sex of Patients

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 2
Page: 2424-2433
Authors: Christine Cornforth, Edmund Sonuga-Barke and David Coghill

The Role of the Nervous System in the Regulation of Liver Cytochrome P450

Journal: Current Drug Metabolism
Volume: 12,Issue: 2
Page: 124-138
Authors: Jacek Wojcikowski and Wladyslawa Anna Daniel

Poly-Si Nanowire Device Technology

Journal: Nanoscience & Nanotechnology-Asia
Volume: 1,Issue: 2
Page: 109-122
Authors: Horng-Chih Lin

Calpain as a Potential Therapeutic Target in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 3
Page: 305-312
Authors: Supriti Samantaray, Swapan K. Ray and Naren L. Banik

The Regulation of Liver Cytochrome P450 by the Brain Dopaminergic System

Journal: Current Drug Metabolism
Volume: 8,Issue: 6
Page: 631-638
Authors: Jacek Wojcikowski, Krystyna Golembiowska and Wladyslawa Anna Daniel

Cannabinoids and Schizophrenia: Therapeutic Prospects

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 2194-2204
Authors: P.J. Robson, G.W. Guy and V. Di Marzo

Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 2
Page: 3771-3787
Authors: Philipp Singer, Sylvain Dubroqua and Benjamin K. Yee

Iptakalim Hydrochloride and Neuronal Protection

Journal: Current Neuropharmacology
Volume: 3,Issue: 3
Page: 249-256
Authors: Jie Wu, Makoto Wakui, Hai Wang and Gang Hu

Depot Based Drug Delivery System for the Management of Depression

Journal: Current Drug Delivery
Volume: 8,Issue: 5
Page: 483-493
Authors: Urmila Pilaniya, Kapil Khatri and U. K. Patil

Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 555-571
Authors: M. Ruscica, M. Arvigo, L. Steffani, D. Ferone and P. Magni

Regulation of G-Protein-Coupled Receptor Signalling by the Scaffolding Proteins Spinophilin/Neurabin 2 and Neurabin 1

Journal: Current Chemical Biology
Volume: 5,Issue: 2
Page: 130-141
Authors: Denis Sarrouilhe and Thierry Metaye

Pharmacogenetic Analysis of SNPs in Genes Involved in the Pharmacokinetics and Response to Lopinavir/Ritonavir Therapy

Journal: Current Drug Metabolism
Volume: 14,Issue: 7
Page: 729-737
Authors: E. López Aspiroz, S.E. Cabrera Figueroa, G.L. Porras Hurtado, G.L. Porras Hurtado, R. Cruz Guerrero, A. Domínguez-Gil Hurlé, A. Carracedo and The Tormes Team

Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2746-2763
Authors: W.-Y. Ong, T. Farooqui and A.A. Farooqui

A Fluorescence Polarization Based Screening Assay for Identification of Small Molecule Inhibitors of the PICK1 PDZ Domain

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 14,Issue: 7
Page: 590-600
Authors: Thor S. Thorsen, Kenneth L. Madsen, Tino Dyhring, Anders Bach, Dan Peters, Kristian Stromgaard and Ulrik Gether

Serotonin 5-HT2A and 5-HT2C Receptors as Potential Targets for Modulation of Psychostimulant Use and Dependence

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 1971-1985
Authors: Marcy J. Bubar and Kathryn A. Cunningham

Peripheral Biomarkers to Assess Suicide Risk

Journal: Current Psychiatry Reviews
Volume: 13,Issue: 1
Page: 43-54
Authors: H. O. Kalkman*

Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors:Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure

Journal: Current Neuropharmacology
Volume: 9,Issue: 3
Page: 478-511
Authors: Sarah K. Williams, Jean M. Lauder and Josephine M. Johns

“Liking” and “Wanting” Linked to Reward Deficiency Syndrome (RDS): Hypothesizing Differential Responsivity in Brain Reward Circuitry

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 113-118
Authors: Kenneth Blum, Eliot Gardner, Marlene Oscar-Berman and Mark Gold

Metabotropic Glutamate Receptors in the Control of Mood Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 2
Page: 87-100
Authors: Jeffrey M. Witkin, Gerard J. Marek, Bryan G. Johnson and Darryle D. Schoepp

Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 428-437
Authors: Mario Catena-Dell'Osso, Donatella Marazziti, Francesco Rotella and Cesario Bellantuono

Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives

Journal: Current Drug Targets
Volume: 15,Issue: 2
Page: 210-253
Authors: Arunachalam Muthuraman, Nirmal Singh, Amteshwar Singh Jaggi and Muthusamy Ramesh

Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in Rats

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 220-232
Authors: Henrike Rippberger, Marcel M. van Gaalen, Rainer K.W. Schwarting and Markus Wohr

Prediction of Ropinirole Urine Level: An Application of the Adaptive- Network-Based Fuzzy Inference System (ANFIS) in Pharmaceutical Analysis

Journal: Current Analytical Chemistry
Volume: 14,Issue: 0
Page: 1-7
Authors: Mahnaz Qomi*, Marjan Gholghasemi, Farhad Azadi and Parviz Raoufi

A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies

Journal: Current Protein & Peptide Science
Volume: 19,Issue: 6
Page: 598-611
Authors: Larisa Ryskalin, Carla L. Busceti, Fiona Limanaqi, Francesca Biagioni, Stefano Gambardella and Francesco Fornai*

Molecular Insights of CREB and MAP-K Phosphorylation by Modafinil in Wake-Related Brain Areas

Journal: Current Molecular Pharmacology
Volume: 11,Issue: 2
Page: 140-148
Authors: Ramses Jimenez-Moreno, Adrian A. Farret-Ramos, Adriana Valle-Ayala, Niurka Trujillo-Paredes and Eric Murillo-Rodriguez*

Glycogen Synthase Kinase-3? as a Putative Therapeutic Target for Bipolar Disorder

Journal: Current Drug Metabolism
Volume: 19,Issue: 0
Page: 1-11
Authors: Manoj P. Dandekar, Samira S. Valvassori, Gustavo Colombo Dal-Pont and Joao Quevedo *

Evaluation of In Silico Anti-parkinson Potential of ?-asarone

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 18,Issue: 0
Page: 1-8
Authors: Meenakshi Gupta, Kamal Kant, Ruchika Sharma and Anoop Kumar*

Stress is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 2
Page: 4029-4041
Authors: Sandor Szabo*, Masashi Yoshida, Janos Filakovszky and Gyorgy Juhasz

Novel Insight into Cholinergic Factors Associated with Schizophrenia and Autoimmunity

Journal: Current Immunology Reviews
Volume: 6,Issue: 4
Page: 273-286
Authors: Leonor Sterin-Borda and Enri Borda



Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 5
Page: 612-626
Authors: Scott D. Gleason, Akihiko Kato, Hai H. Bui, Linda K. Thompson, Sabrina N. Valli, Patrick V. Stutz, Ming-Shang Kuo, Julie F. Falcone, Wesley H. Anderson, Xia Li and Jeffrey M. Witkin

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 5
Page: 489-507
Authors: Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina and Rita Raisman-Vozari

The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3,Issue: 4
Page: 283-310
Authors: Jason C.G. Halford, Gillian D. Cooper, Terence M. Dovey, Yuko Ishii, John Rodgers and John E. Blundell

Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4,Issue: 1
Page: 85-98
Authors: Konstantin G. Karageuzyan

Recent Strategies for Potentiation and Facilitation of Antidepressant Treatment: Introduction

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 137-137
Authors: Bernard Lerer

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 6
Page: 531-531
Authors: Craig W. Lindsley

Results 1 - 631 of 631